Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3009991	li-ace	— (—)	1656	1727	100.00%	Distribution not available
3009991	li-ace	U/l (u/l)	1126	1215	2.80%
3009991	li-ace	U/l_______ (u/l)	7	7	0.00%	Distribution not available
3009991	li-ace	U/L (u/l)	6	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormal findings on diagnostic imaging of central nervous system

238

119

22.36

315.85

1.1

1.11

1.16

u/l

0.19

105

Disorders of optic nerve and visual pathways

291

224

13.88

308.03

1.2

1.0

1.13

1.12

u/l

0.02

107

103

Other degenerative diseases of the nervous system

624

113

41.81

307.65

1.1

1.0

1.00

1.17

u/l

1.53

228

Neurological diseases

795

360

11.22

307.65

1.1

1.0

1.06

1.16

u/l

1.06

308

149

Other symptoms and signs involving the nervous and musculoskeletal systems

709

861

8.46

307.65

1.1

1.08

1.12

u/l

0.50

304

319

Demyelinating diseases of the central nervous system

542

203

30.97

307.65

1.1

0.99

1.05

u/l

0.91

196

Other demyelinating diseases of the central nervous system

306

41.64

307.65

1.1

1.01

1.08

u/l

0.56

116

Symptoms and signs involving the nervous and musculoskeletal systems

908

1184

7.85

307.65

1.1

1.08

1.15

u/l

0.75

397

458

MS-disease / Multiple Sclerosis

442

167

30.55

307.65

1.0

1.1

0.96

1.04

u/l

1.54

146

Disturbances of skin sensation

549

725

7.83

307.65

1.1

1.08

1.14

u/l

0.70

209

291

Polyneuropathies and other disorders of the peripheral nervous system

350

368

9.81

299.19

1.1

1.15

u/l

0.01

164

170

Visual disturbances and blindness

621

1211

5.21

298.38

1.1

1.13

1.11

u/l

0.15

257

490

Visual disturbances

600

1144

5.34

296.33

1.1

1.12

1.11

u/l

0.10

249

466

Neurological diseases, wide definition

333

26.95

284.22

1.1

1.0

1.01

1.16

u/l

0.33

128

Other and unspecified polyneuropathies, also in other diseases

311

309

10.39

277.11

1.1

1.12

1.14

u/l

0.06

145

146

Headache

692

1189

4.55

260.40

1.1

1.10

1.08

u/l

0.19

286

472

Symptoms and signs involving the skin and subcutaneous tissue

725

1746

3.97

244.25

1.1

1.07

1.13

u/l

0.68

281

734

Postprocedural disorders of nervous system

231

185

13.37

238.89

1.1

1.0

1.10

1.06

u/l

0.20

101

Autoimmune diseases related-to ILD

798

1870

3.60

226.05

1.1

1.05

1.14

u/l

1.82

291

795

Other neurological diseases

649

1219

4.17

220.00

1.1

1.18

1.12

u/l

0.51

274

515

Autoimmune diseases excluding thyroid diseases

885

1387

3.49

207.03

1.1

1.05

1.13

u/l

1.17

339

559

ILD medications: immunosuppressive drugs

617

1437

3.93

203.08

1.1

1.07

1.16

u/l

1.20

261

569

Autoimmune diseases excluding thyroid diseases, strict definition

856

1342

3.50

201.48

1.1

1.05

1.13

u/l

0.98

327

541

Diplopia

228

236

10.00

197.42

1.1

1.16

1.20

u/l

0.17

109

Optic neuritis

167

107

17.16

196.62

1.1

1.0

0.99

1.06

u/l

0.76

Concussion

273

263

8.10

180.45

1.1

1.0

1.14

1.18

u/l

0.18

107

108

Intracranial trauma

297

267

7.56

173.38

1.1

1.0

1.17

u/l

0.03

117

110

Encephalitis

129

21.79

169.37

1.4

1.0

1.16

1.06

u/l

0.53

Inflammatory diseases of the central nervous system

190

192

10.38

167.87

1.3

1.1

1.22

1.13

u/l

0.56

ILD medications

880

1579

3.03

165.85

1.1

1.04

1.14

u/l

2.12

361

617

Other encephalitis

124

22.74

165.65

1.4

1.0

1.16

1.08

u/l

0.44

Symptoms and signs involving cognition, perception, emotional state and behaviour

786

1722

3.07

163.26

1.1

1.08

1.13

u/l

0.61

301

728

General symptoms and signs

786

1270

3.12

151.78

1.1

1.15

1.09

u/l

0.50

325

509

Other disorders of optic [2nd] nerve and visual pathways

152

140

11.45

143.40

1.2

1.0

1.24

1.16

u/l

0.33

Other symptoms and signs involving cognitive functions and awareness

367

742

4.43

140.74

1.1

1.13

1.14

u/l

0.09

138

328

Subjective visual disturbances

290

570

5.18

138.76

1.1

1.12

u/l

0.00

129

235

Autoimmune diseases

784

1391

2.88

133.44

1.1

1.11

1.13

u/l

0.18

316

561

Abnormalities of gait and mobility

154

163

9.70

131.03

1.1

1.25

1.26

u/l

0.03

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

497

1287

3.39

130.60

1.1

1.15

u/l

0.03

225

530

Sarcoidosis

197

286

7.09

129.10

1.4

1.0

1.23

1.14

u/l

0.62

102

137

Used for control exclusion in common control thyroid runs

723

1265

2.90

124.38

1.1

1.05

1.13

u/l

1.06

293

504

Papilloedema, unspecified

19.94

122.47

1.3

1.0

1.14

1.08

u/l

0.24

Benign intracranial hypertension

37.45

120.50

1.2

1.0

1.11

1.05

u/l

0.27

Nerve, nerve root and plexus disorders

762

1755

2.62

115.94

1.1

1.11

1.13

u/l

0.18

332

696

Malaise and fatigue

382

805

3.77

114.05

1.1

1.16

1.11

u/l

0.32

155

320

Certain disorders involving the immune mechanism

227

439

5.28

110.86

1.4

1.0

1.21

1.15

u/l

0.39

114

187

Paralytic strabismus

122

126

10.06

105.98

1.1

1.27

1.17

u/l

0.34

ILD medications: prednisolone, methylprednisolone, prednisone

710

1542

2.57

101.79

1.1

1.08

1.15

u/l

0.86

308

606

Diagnoses used for exclusion with ILD

235

506

4.71

101.00

1.3

1.1

1.26

1.12

u/l

1.11

118

210

Dizziness and giddiness

516

1402

2.88

100.67

1.1

1.05

1.13

u/l

1.12

215

585

Bell's palsy

157

242

6.65

97.24

1.1

1.14

1.17

u/l

0.12

110

Diseases of the eye and adnexa

572

1002

2.88

97.18

1.1

1.06

1.14

u/l

0.86

223

404

Cerebral cysts

119

135

9.20

96.45

1.2

1.0

1.14

1.06

u/l

0.34

L04AX Other immunosuppressants

448

1544

2.93

95.40

1.2

1.1

1.08

1.14

u/l

0.65

199

621

Migraine

434

1135

3.00

90.88

1.1

1.06

1.08

u/l

0.16

182

442

Second line medication for Crohn's disease

453

1613

2.83

90.76

1.2

1.1

1.09

1.15

u/l

0.67

202

652

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

220

189

5.88

89.57

1.1

1.0

1.06

1.12

u/l

0.29

Cerebral palsy and other paralytic syndromes

148

239

6.35

87.63

1.1

1.34

1.11

u/l

1.00

107

Other soft tissue disorders, not elsewhere classified

652

1512

2.47

86.58

1.1

1.12

u/l

0.01

269

600

Other headache syndromes

335

1033

3.26

86.06

1.1

1.13

1.09

u/l

0.40

125

407

Episodal and paroxysmal disorders

689

1456

2.41

84.41

1.1

1.10

1.09

u/l

0.16

268

594

Use of teriflunomide

25.48

84.14

1.0

1.1

0.97

1.25

u/l

0.88

Dorsalgia

649

1410

2.45

83.35

1.1

1.09

u/l

0.00

259

548

Disorders of ocular muscles, binocular movement, accommodation and refraction

407

1430

2.85

82.37

1.1

1.16

1.08

u/l

0.67

165

552

Other dorsopathies, not elsewhere classified

653

1417

2.41

80.18

1.1

1.07

1.09

u/l

0.24

257

548

L04AA Selective immunosuppressants

226

579

3.97

77.62

1.1

1.08

1.13

u/l

0.42

243

Small fibre neuropathy

14.48

77.27

1.1

1.0

1.08

1.12

u/l

0.18

Low back pain

517

1382

2.54

76.62

1.1

1.08

1.09

u/l

0.08

199

538

Systemic atrophies primarily affecting the central nervous system

11.79

76.37

1.1

1.06

1.09

u/l

0.19

Cerebrovascular diseases (FINNGEN)

269

513

3.71

75.90

1.1

1.24

1.16

u/l

0.31

108

222

Guillain-Barre syndrome

21.23

75.48

1.1

1.0

1.24

1.16

u/l

0.16

Infections, IBD-co-morbidities

16.46

74.58

1.2

1.0

1.27

1.39

u/l

—

Strabismus

249

702

3.58

74.00

1.1

1.24

1.08

u/l

1.21

109

282

Oral corticosteroids

677

1805

2.21

71.26

1.2

1.0

1.11

u/l

0.01

294

718

Pain, not elsewhere classified

215

569

3.82

70.40

1.0

1.1

1.23

1.14

u/l

0.17

205

Care involving use of rehabilitation procedures

435

1546

2.55

69.54

1.1

1.25

1.08

u/l

0.86

172

632

General examination and investigation of persons without complaint and reported diagnosis

388

691

2.93

69.16

1.1

1.14

u/l

0.00

149

302

Pain in joint

362

758

2.95

69.04

1.1

1.02

1.14

u/l

2.39

144

308

Condition for Implicit Sepsis (Organ dysfunction codes)

537

1582

2.36

68.93

1.1

1.10

1.13

u/l

0.32

222

654

Medical observation and evaluation for suspected diseases and conditions

391

691

2.91

68.37

1.1

1.06

1.14

u/l

0.64

158

302

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

577

1713

2.28

68.18

1.1

1.11

1.12

u/l

0.13

234

701

Inflammatory bowel disease treatment related agents

717

1885

2.12

67.21

1.2

1.0

1.13

1.10

u/l

0.26

302

744

First line medication for Crohn's disease

690

1728

2.16

67.06

1.2

1.0

1.10

u/l

0.02

299

664

Dorsopathies

630

1421

2.26

66.80

1.1

1.09

1.10

u/l

0.14

249

551

Pain in limb

542

1480

2.34

66.52

1.1

1.14

1.12

u/l

0.23

220

589

Cerebrovascular diseases

412

1091

2.63

66.22

1.1

1.16

1.15

u/l

0.10

171

483

Anxiety disorders, excluding more controls

538

1479

2.34

65.94

1.1

1.11

1.13

u/l

0.13

221

624

Implicit Sepsis, including avohilmo

511

1556

2.36

65.80

1.1

1.08

1.14

u/l

0.60

213

638

Abnormal involuntary movements

127

236

5.47

64.95

1.0

1.1

1.00

1.20

u/l

2.37

105

Migraine with aura

231

681

3.43

64.40

1.1

1.03

1.09

u/l

0.67

264

Other special examinations and investigations of persons without complaint or reported diagnosis

384

691

2.83

63.96

1.1

1.07

1.14

u/l

0.55

142

302

Epilepsy

218

620

3.54

63.85

1.1

1.11

1.10

u/l

0.07

254

Disorders of thyroid, IBD co-morbidities

12.49

63.56

1.1

1.0

1.15

1.28

u/l

0.15

Fever of other and unknown origin

328

1021

2.80

62.74

1.1

1.19

1.09

u/l

0.95

150

409

Anxiety disorders

595

1901

2.16

61.63

1.1

1.10

1.12

u/l

0.21

242

770

Neurotic, stress-related and somatoform disorders

590

1899

2.15

60.69

1.1

1.10

1.13

u/l

0.23

240

767

Mood disorders, excluding more controls

567

1529

2.19

58.60

1.1

1.09

1.13

u/l

0.38

211

643

Neuromuscular dysfunction of bladder

104

180

5.90

57.49

1.1

1.02

1.09

u/l

0.73

Lower back pain or/and sciatica

661

2029

2.03

57.45

1.1

1.10

1.12

u/l

0.22

269

824

STROKE

355

912

2.64

56.83

1.1

1.20

1.16

u/l

0.23

144

397

Depression

606

1961

2.08

56.59

1.1

1.09

1.13

u/l

0.46

221

825

Implicit Sepsis

441

1413

2.31

54.79

1.1

1.09

1.13

u/l

0.28

180

593

Other intervertebral disc disorders

473

1242

2.28

54.12

1.1

1.07

1.11

u/l

0.32

197

492

Sixth [abducent] nerve palsy

10.09

52.18

1.2

1.0

1.36

1.13

u/l

0.59

Mood [affective] disorders

617

1985

2.00

51.66

1.1

1.08

1.13

u/l

0.49

224

835

Mood disorders

617

1985

2.00

51.39

1.1

1.08

1.13

u/l

0.49

224

835

Other acute disseminated demyelination

18.72

51.23

1.1

0.99

1.09

u/l

0.36

Myalgia

190

594

3.23

48.37

1.1

1.08

1.13

u/l

0.42

221

Dysphagia

167

482

3.50

48.26

1.1

1.10

1.12

u/l

0.09

203

Other and unspecified visual disturbances

106

220

4.90

47.94

1.0

1.1

1.02

1.18

u/l

1.28

104

Sciatica+with lumbago

314

1127

2.48

47.66

1.1

1.09

1.12

u/l

0.18

134

449

Malignant neoplasm of brain, including Hilmo

7.24

46.31

1.1

1.65

1.11

u/l

1.89

Other disorders of eye and adnexa

142

379

3.80

46.26

1.1

1.14

u/l

0.01

156

Persons encountering health services for specific procedures and health care

633

1957

1.92

46.17

1.1

1.20

1.07

u/l

1.03

262

781

Other disorders of lacrimal gland

248

923

2.71

46.14

1.1

1.06

1.14

u/l

0.69

106

362

Third [oculomotor] nerve palsy

13.35

45.58

1.0

1.18

1.14

u/l

0.12

Lumbar disc prolapse

367

1188

2.30

45.30

1.1

1.15

1.11

u/l

0.24

142

472

Other antidepressants

560

1429

2.01

44.92

1.1

1.06

1.14

u/l

1.12

234

586

Systemic connective tissue disorders

224

804

2.81

44.70

1.1

1.16

1.12

u/l

0.24

326

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

134

6.02

44.65

1.1

2.01

1.09

u/l

1.54

Any reimbursement code in KELA

389

842

2.33

44.39

1.1

1.06

1.08

u/l

0.23

163

328

Soft tissue disorders

583

1523

1.97

44.30

1.1

1.07

1.12

u/l

0.50

234

602

Migraine without aura

181

580

3.15

44.28

1.1

1.13

1.12

u/l

0.07

224

Non-invasive ventilation

182

498

3.18

43.62

1.1

1.12

1.17

u/l

0.28

208

Convulsions, not elsewhere classified

157

461

3.39

43.22

1.1

1.02

1.07

u/l

0.46

177

Pain (limb, back, neck, head abdominally)

361

764

2.38

43.19

1.1

1.05

1.14

u/l

1.52

154

309

Examination and observation for other reasons

306

686

2.53

43.10

1.1

1.15

1.14

u/l

0.02

102

300

Implicit viral Sepsis, including avohilmo

191

641

3.00

42.90

1.2

1.1

1.13

1.11

u/l

0.07

257

Stroke, excluding SAH

286

823

2.52

42.87

1.1

1.17

1.15

u/l

0.08

117

375

Spirochaetal infections, other/unspecified

198

4.84

41.86

1.1

1.36

1.15

u/l

0.81

Anxiety (asthma-related co-morbidities)

417

1513

2.11

41.82

1.1

1.04

1.13

u/l

1.24

163

621

Disorders of lacrimal system

271

1089

2.46

41.49

1.1

1.07

1.13

u/l

0.60

119

423

Ischaemic Stroke, excluding all haemorrhages

264

761

2.57

41.27

1.1

1.18

1.15

u/l

0.10

108

343

Other lack of coordination

14.34

41.10

1.1

1.19

1.02

u/l

0.40

Ocular pain

214

4.62

40.85

1.1

1.05

1.13

u/l

0.75

Enlarged lymph nodes

116

293

4.00

40.81

1.1

1.10

u/l

0.01

114

Malignant neoplasm of brain

8.33

40.75

1.1

1.47

1.07

u/l

1.23

All anxiety disorders

429

1626

2.06

40.69

1.1

1.04

1.13

u/l

1.15

167

640

Stroke, including SAH

299

897

2.40

40.53

1.1

1.19

1.14

u/l

0.25

122

406

Recurrent or chronic depression

259

701

2.58

40.24

1.1

1.10

1.19

u/l

0.62

100

289

Other general symptoms and signs

6.93

39.41

1.1

1.0

1.01

1.19

u/l

1.04

Tramadol

449

1331

2.04

39.16

1.1

1.11

1.14

u/l

0.22

175

529

Spondylopathies

392

1086

2.14

38.82

1.1

1.17

1.12

u/l

0.46

161

439

Viral infections of the central nervous system, including avohilmo

205

4.58

38.31

1.3

1.1

1.55

1.12

u/l

0.54

Any mental disorder

572

1534

1.87

37.63

1.1

1.09

1.13

u/l

0.39

234

646

Chorioretinal inflammation

8.34

36.92

1.3

1.1

1.17

1.12

u/l

0.16

Migraine with aura and triptan purchases

160

533

3.04

36.78

1.1

1.07

u/l

0.01

187

GASTRO-related operations

450

1125

2.01

36.38

1.1

1.09

1.07

u/l

0.17

178

431

Any gastric operation

450

1125

2.01

36.38

1.1

1.09

1.07

u/l

0.17

178

431

Malignant neoplasm of eye, brain and central nervous system

6.80

36.22

1.1

1.53

1.08

u/l

1.41

Depression or dysthymia

341

842

2.22

36.08

1.1

1.05

1.17

u/l

1.33

133

360

Pain in throat and chest

490

1519

1.92

36.00

1.1

1.08

1.14

u/l

0.64

205

613

Focal epilepsy, strict definition

140

439

3.22

35.60

1.1

1.11

1.14

u/l

0.19

183

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

537

1979

1.83

35.58

1.2

1.1

1.24

1.09

u/l

1.33

245

798

Cardiovascular diseases

422

1106

2.03

35.58

1.1

1.02

1.11

u/l

0.97

163

423

Radiculopathy

243

4.07

35.41

1.1

1.03

1.14

u/l

0.90

105

Asthma, excluding more controls

417

1051

2.04

35.34

1.1

1.0

1.05

1.13

u/l

0.86

167

423

Asthma

420

1071

2.03

34.99

1.1

1.0

1.05

1.13

u/l

0.86

167

431

Other/unspecified dorsalgia

216

851

2.52

34.92

1.1

1.13

1.14

u/l

0.03

332

Other anxiety disorders

333

1347

2.12

34.70

1.1

1.05

1.09

u/l

0.36

129

533

Focal epilepsy

150

498

3.04

34.62

1.1

1.10

1.13

u/l

0.19

203

Opioids

548

1547

1.84

34.19

1.1

1.06

1.12

u/l

0.79

205

614

Codeine

523

1528

1.86

34.17

1.1

1.04

1.12

u/l

1.22

206

607

Focal epilepsy, mode (most common among epilepsy diagnosis)

135

425

3.21

34.14

1.1

1.11

1.15

u/l

0.18

181

Persons encountering health services for examination and investigation

312

691

2.27

34.02

1.1

1.06

1.14

u/l

0.65

125

302

Depression medications

202

361

2.83

33.89

1.1

0.99

1.05

u/l

0.72

122

Extrapyramidal and movement disorders

208

829

2.52

33.82

1.1

1.01

1.12

u/l

2.65

358

Asthma (mode)

411

1078

2.01

33.54

1.1

1.0

1.06

1.13

u/l

0.73

162

432

ILD medications: azathioprine

114

329

3.50

33.17

1.2

1.0

1.18

u/l

0.01

128

Other specific joint derangements/joint disorders

460

1519

1.89

33.11

1.1

1.04

1.11

u/l

1.03

190

604

Viral encephalitis, not elsewhere classified/unspecified

11.40

33.08

1.5

1.0

2.15

1.14

u/l

0.54

Syncope and collapse

210

696

2.53

33.06

1.1

1.07

1.11

u/l

0.27

282

Viral infections of the central nervous system

196

4.38

33.06

1.3

1.1

1.58

1.13

u/l

0.53

Viral Sepsis

128

398

3.24

33.04

1.2

1.1

1.15

1.16

u/l

0.03

165

Implicit viral Sepsis

127

396

3.23

32.64

1.2

1.1

1.15

1.16

u/l

0.02

163

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

11.04

32.41

1.5

1.0

2.15

1.13

u/l

0.54

Covid-19 confirmed case

210

867

2.43

31.59

1.1

1.14

1.07

u/l

0.63

335

Provisional assignment of new diseases of uncertain etiology

312

1507

2.06

31.40

1.1

1.13

1.11

u/l

0.11

137

596

Codes for special purposes

312

1509

2.06

31.28

1.1

1.13

1.11

u/l

0.12

137

597

Disorders of vestibular function (Vertigo)

246

1073

2.24

30.62

1.1

1.13

1.12

u/l

0.03

456

Meningitis

124

5.21

30.49

1.2

1.1

1.41

1.09

u/l

1.11

Benzodiazepine use

544

2115

1.74

30.41

1.1

1.09

1.12

u/l

0.24

205

877

Fibromyalgia

222

3.98

30.36

1.1

1.03

1.12

u/l

0.81

Hypothyroidism, strict autoimmune

336

1086

2.04

30.17

1.1

1.20

1.11

u/l

0.58

144

433

Speech disturbances, not elsewhere classified

168

4.47

30.12

1.1

1.28

1.14

u/l

0.32

Other systemic involvement of connective tissue (FG)

157

566

2.74

30.06

1.1

1.16

1.09

u/l

0.37

223

Other disorders of urethra and urinary system

381

1375

1.93

30.00

1.1

1.16

1.09

u/l

0.67

173

550

Diseases of the musculoskeletal system and connective tissue

304

705

2.17

29.88

1.1

1.07

1.13

u/l

0.30

128

265

Spondylosis

246

861

2.24

29.27

1.1

1.13

1.15

u/l

0.12

102

359

Abnormalities of breathing

489

1570

1.79

28.85

1.1

1.09

1.13

u/l

0.29

195

627

ILD differential diagnosis

410

1078

1.91

28.84

1.1

1.0

1.09

1.13

u/l

0.35

168

432

COPD differential diagnosis

410

1079

1.91

28.77

1.1

1.09

1.13

u/l

0.35

168

433

Disorders of eyelid, lacrimal system and orbit

452

1850

1.80

28.58

1.1

1.06

1.14

u/l

0.90

201

748

Hemiplegia

105

5.45

28.58

1.1

1.08

1.11

u/l

0.10

Other diseases of spinal cord

7.54

28.54

1.1

1.0

1.45

1.00

u/l

1.02

Alzheimer disease, excluding more controls

7.38

28.32

1.1

1.03

1.31

u/l

0.92

Diseases of inner ear

269

1231

2.10

28.30

1.1

1.12

1.14

u/l

0.12

525

Other meningitis

9.19

28.26

1.2

1.1

1.30

1.08

u/l

0.86

Somatoform disorder

125

422

2.99

28.17

1.1

1.14

u/l

0.00

172

Monoplegia

11.23

27.98

1.1

1.0

1.92

1.11

u/l

—

Symptoms and signs involving speech and voice

192

808

2.39

27.88

1.1

1.11

1.12

u/l

0.02

324

Cervical disc disorders

173

698

2.49

27.52

1.1

1.18

1.17

u/l

0.05

291

Azathioprine

114

371

3.11

27.40

1.2

1.0

1.18

1.13

u/l

0.27

146

Other systemic involvement of connective tissue

161

632

2.57

27.17

1.1

1.15

1.12

u/l

0.16

256

Cardiovascular diseases (excluding rheumatic etc)

412

1280

1.85

27.11

1.1

1.04

1.09

u/l

0.58

166

507

Symptoms and signs involving the digestive system and abdomen

489

1392

1.77

26.88

1.1

1.14

1.12

u/l

0.08

193

570

Persons encountering health services in other circumstances, wide

576

1767

1.68

26.78

1.1

1.12

1.14

u/l

0.13

226

730

Disorders of optic nerve, not elsewhere classified

9.49

26.65

1.1

1.0

1.19

1.11

u/l

0.10

Optic atrophy, wide definition

10.39

26.65

1.1

1.0

1.78

1.09

u/l

0.81

Excluding asthma or asthma-COPD overlap

403

1083

1.87

26.62

1.1

1.0

1.08

1.13

u/l

0.38

166

435

Use of glatiramer acetate

7.79

26.12

1.0

1.1

0.94

1.11

u/l

1.11

Other extrapyramidal and movement disorders in other diseases

146

559

2.63

25.96

1.1

1.03

1.13

u/l

1.87

237

Symptoms and signs involving the circulatory and respiratory systems

535

1581

1.70

25.86

1.1

1.07

1.13

u/l

0.58

211

631

Symptoms and signs involving the urinary system

371

1521

1.85

25.85

1.1

1.19

1.13

u/l

0.37

148

642

Primary_lymphoid and hematopoietic malignant neoplasms

125

443

2.84

25.80

1.2

1.1

1.28

1.13

u/l

0.90

192

Use of peginterferon beta-1a

30.94

25.78

1.0

1.1

0.97

0.99

u/l

—

Visual field defects

143

4.47

25.69

1.1

1.27

1.18

u/l

0.24

Parasetamol

393

1071

1.86

25.65

1.1

1.03

1.15

u/l

1.82

161

423

Asthma (only as main-diagnosis)

362

1071

1.90

25.63

1.1

1.0

1.02

1.13

u/l

1.35

143

431

Other facial nerve disorders

6.87

25.61

1.1

1.0

1.40

1.10

u/l

0.57

Asthma (only as main-diagnosis), excluding more controls

360

1051

1.90

25.59

1.1

1.0

1.02

1.13

u/l

1.35

143

423

Paraplegia, diplegia of upper limbs

8.95

25.54

1.2

1.1

1.98

1.11

u/l

1.16

Follow-up examination after treatment for conditions other than malignant neoplasms

205

591

2.32

25.50

1.0

1.1

0.99

1.15

u/l

1.55

258

Optic atrophy

9.76

25.46

1.1

1.0

1.78

1.11

u/l

0.78

Other pulmonary diagnosis

398

1083

1.85

25.34

1.1

1.0

1.09

1.13

u/l

0.36

161

435

Cervicalgia

120

421

2.87

25.25

1.1

1.12

1.13

u/l

0.03

164

Other disorders of binocular movement

6.98

25.22

1.1

0.98

1.09

u/l

0.66

Oedema, not elsewhere classified

143

536

2.62

25.14

1.1

1.11

1.12

u/l

0.04

208

Triptan medication for migraine, single purchase ok

445

1736

1.74

25.08

1.1

1.10

1.12

u/l

0.12

179

689

Migraine, single triptan purchase ok & required. ICD-code if available is included

445

1736

1.74

25.08

1.1

1.10

1.12

u/l

0.12

179

689

Anaemias

138

317

2.81

24.86

1.1

1.53

1.07

u/l

0.74

108

Codeine or tramadol medication

586

1963

1.63

24.40

1.1

1.04

1.12

u/l

1.85

225

797

Migraine without aura and triptan purchases

144

566

2.57

24.36

1.1

1.16

1.07

u/l

0.58

198

Diseases of the myoneural junction and muscle

239

3.51

24.36

1.1

1.05

1.16

u/l

0.41

114

Psychiatric diseases

471

1366

1.73

24.33

1.1

1.08

1.11

u/l

0.39

185

585

Certain infectious and parasitic diseases

490

1438

1.71

24.29

1.1

1.17

1.05

u/l

1.67

202

565

Asthma, unspecified (mode)

271

975

2.01

24.21

1.1

1.0

1.05

1.13

u/l

0.78

103

390

Abdominal and pelvic pain

476

1392

1.72

24.11

1.1

1.16

1.12

u/l

0.21

191

570

Other reaction to severe stress, and adjustment disorders

241

1185

2.04

23.83

1.1

1.14

1.10

u/l

0.24

469

Sequelae of cerebrovascular disease

148

500

2.54

23.80

1.0

1.1

1.31

1.12

u/l

0.80

232

Hard cardiovascular diseases

393

1299

1.79

23.76

1.1

1.14

1.16

u/l

0.14

174

561

Asthma, unspecified (mode), excluding more controls

268

959

2.01

23.71

1.1

1.0

1.06

1.13

u/l

0.72

101

384

Non-Hodgkin lymphoma, all, including Hilmo

229

3.53

23.69

1.2

1.1

1.36

1.12

u/l

1.02

Other and unspecified nerve root and plexus disorders, also in other diseases

127

478

2.68

23.43

1.1

1.12

1.11

u/l

0.05

195

Other diseases of urinary system

491

1646

1.68

23.34

1.1

1.14

1.10

u/l

0.35

209

674

Implicit bacterial Sepsis, including avohilmo

197

745

2.21

23.06

1.1

1.13

1.15

u/l

0.10

319

Factors influencing health status and contact with health services

135

240

2.83

22.95

1.1

1.10

1.09

u/l

0.09

103

Parkinson's disease, excluding more controls

7.18

22.93

1.1

1.0

1.02

1.38

u/l

1.16

Other strabismus

145

587

2.48

22.84

1.1

1.17

1.09

u/l

0.42

242

Cervicobrachial syndrome

125

473

2.66

22.82

1.1

0.99

1.13

u/l

2.53

185

Heterophoria

193

3.73

22.76

1.0

1.1

1.01

1.12

u/l

0.76

Persons encountering health services for other counselling and medical advice, not elsewhere classified

541

1767

1.63

22.75

1.1

1.14

u/l

0.02

216

730

Parkinson's disease, strict definition, excluding more controls

7.54

22.65

1.2

1.0

1.00

1.39

u/l

1.08

Antihypertensive medication - note that there are other indications

384

1122

1.79

22.63

1.1

1.04

1.13

u/l

1.19

136

462

Other necrotizing vasculopathies (FG)

101

4.93

22.51

1.2

1.0

1.14

1.20

u/l

0.21

Trigeminal neuralgia

109

4.75

22.45

1.1

1.07

1.15

u/l

0.33

Hypothyroidism (congenital or acquired)

154

339

2.56

22.44

1.1

1.05

1.06

u/l

0.12

116

Neuralgia and neuritis, unspecified

5.08

22.36

1.1

1.14

1.20

u/l

0.15

Selective serotonin reuptake inhibitors

464

1429

1.69

22.35

1.1

1.08

1.14

u/l

0.58

185

586

Liquid cancers

143

552

2.46

22.09

1.2

1.1

1.25

1.07

u/l

1.31

224

Status epilepticus

6.79

21.73

1.2

1.0

1.00

1.24

u/l

1.01

Hypothyroidism, levothyroxine purchases

152

339

2.53

21.66

1.1

1.06

u/l

0.01

116

Hypothyroidism and >3 levothyroxin purchases

152

339

2.53

21.66

1.1

1.06

u/l

0.01

116

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

171

755

2.25

21.64

1.1

1.07

1.08

u/l

0.07

292

Other symptoms and signs involving the urinary system

203

3.54

21.12

1.2

1.1

1.07

1.16

u/l

0.48

Metabolic disorders

465

1696

1.65

21.03

1.1

1.20

1.11

u/l

0.74

196

678

Lesion of lateral popliteal nerve

4.83

20.61

1.0

1.1

1.05

1.13

u/l

0.33

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

4.79

20.51

1.0

1.56

1.27

u/l

0.38

Brachial plexus disorders

237

3.29

20.45

1.1

1.20

1.09

u/l

0.43

Other joint disorders

481

1540

1.63

20.34

1.1

1.08

1.11

u/l

0.27

188

608

Diseases of the ear and mastoid process

581

1874

1.56

20.02

1.1

1.11

u/l

0.00

240

755

Disorders of refraction and accommodation

172

800

2.15

19.65

1.1

1.10

u/l

0.02

331

Visual impairment including blindness (binocular or monocular)

109

4.46

19.63

1.1

1.06

1.22

u/l

1.05

Atypical facial pain

4.76

19.42

1.1

1.11

1.05

u/l

0.35

107

409

2.64

19.27

1.1

1.09

u/l

0.03

165

Oxycodone

171

683

2.15

18.94

1.1

1.25

1.18

u/l

0.34

298

Exclusions for E4_PCOS_BROAD

118

479

2.48

18.73

1.2

1.1

1.26

1.08

u/l

0.96

198

Implicit bacterial Sepsis

170

683

2.14

18.69

1.2

1.1

1.15

1.10

u/l

0.21

291

Benign neoplasm of meninges

205

3.35

18.69

1.1

1.05

1.19

u/l

0.98

100

Other necrotizing vasculopathies

131

4.02

18.61

1.2

1.1

1.14

1.17

u/l

0.12

Other and unspecified dermatitis

270

1505

1.80

18.44

1.1

1.13

1.12

u/l

0.05

120

616

Iridocyclitis in diseases classified elsewhere

7.66

18.33

1.4

1.0

1.11

1.09

u/l

0.04

Transient ischemic attack

194

765

2.03

18.20

1.1

1.19

1.12

u/l

0.53

340

Abnormal findings on diagnostic imaging of lung

184

857

2.04

18.18

1.2

1.1

1.21

1.16

u/l

0.24

380

Autonomic disorders

6.83

17.93

1.0

1.24

1.02

u/l

—

Disorders of sclera, cornea, iris and ciliary body

283

1614

1.76

17.91

1.1

1.12

1.13

u/l

0.02

130

650

Benign neoplasm: Cerebral meninges

191

3.39

17.90

1.1

1.04

1.21

u/l

1.22

Disorders of other endocrine glands

233

1233

1.87

17.86

1.1

1.27

1.08

u/l

1.29

101

488

Irritable bowel syndrome

166

797

2.09

17.72

1.1

1.07

1.14

u/l

0.46

326

Organic, including symptomatic, mental disorders

189

653

2.04

17.66

1.1

1.12

u/l

0.05

307

Non-Hodgkin lymphoma, all

5.80

17.60

1.2

1.1

1.73

1.14

u/l

1.39

Myasthenia gravis

8.00

17.52

1.1

1.0

0.95

1.13

u/l

—

Dermatitis

309

1783

1.70

17.25

1.1

1.13

1.11

u/l

0.15

133

735

Spinal stenosis

176

629

2.07

17.20

1.1

1.14

1.16

u/l

0.09

290

Diffuse large B-cell lymphoma

5.07

17.17

1.2

1.1

1.17

1.15

u/l

0.05

Diffuse large B-cell lymphoma, including Hilmo

5.07

17.17

1.2

1.1

1.17

1.15

u/l

0.05

Diffuse large B-cell lymphoma, helper endpoint

5.07

17.17

1.2

1.1

1.17

1.15

u/l

0.05

Use of hypnotics and sedatives

513

1918

1.53

17.03

1.1

1.15

1.12

u/l

0.22

203

794

Nausea and vomiting

131

570

2.25

16.75

1.1

1.25

1.16

u/l

0.42

233

Triptan medication for migraine, min. 3 purchases

350

1592

1.65

16.65

1.1

1.13

1.08

u/l

0.46

139

618

Hypertensive diseases (excluding secondary)

287

951

1.76

16.52

1.1

1.12

u/l

0.03

104

379

Liquid cancers, including Hilmo

157

665

2.09

16.36

1.2

1.1

1.22

1.07

u/l

1.22

277

Cystitis

392

1450

1.61

16.34

1.1

1.11

1.07

u/l

0.33

148

576

Other disorders of fluid, electrolyte and acid-base balance

131

555

2.23

16.32

1.1

1.16

1.08

u/l

0.38

240

Retention of urine

142

528

2.18

16.26

1.1

1.26

1.12

u/l

0.49

234

Bacterial Sepsis

186

784

1.97

16.25

1.1

1.21

1.14

u/l

0.32

337

Special screening examination for infectious and parasitic diseases

140

463

2.22

16.23

1.1

0.97

1.16

u/l

1.43

194

Hypothyroidism, drug reimbursement

196

2.90

16.07

1.1

0.99

1.04

u/l

0.43

Delirium, not induced by alcohol and other psychoactive substances

164

3.43

16.06

1.1

1.06

1.17

u/l

0.62

Post-traumatic stress disorder

269

2.86

15.97

1.1

0.99

1.04

u/l

0.31

Dyspnoea

421

1954

1.56

15.83

1.1

1.10

1.13

u/l

0.19

177

801

Finngen Rheumatological endpoints

486

1813

1.52

15.83

1.1

1.14

1.11

u/l

0.26

196

731

Polyuria

107

450

2.39

15.81

1.1

0.98

1.13

u/l

1.97

196

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

256

1418

1.75

15.76

1.1

1.08

1.14

u/l

0.45

106

568

Symptoms and signs concerning food and fluid intake

157

3.46

15.68

1.2

1.0

1.09

1.17

u/l

0.33

Asthma, including avohilmo

565

2112

1.48

15.66

1.1

1.08

1.13

u/l

0.53

230

857

Iridocyclitis

126

574

2.21

15.46

1.2

1.1

1.20

1.12

u/l

0.29

230

Other and unspecified degenerative diseases of nervous system

6.54

15.42

1.1

1.0

1.01

1.13

u/l

—

Abnormal findings on diagnostic imaging of other body structures

285

2.76

15.42

1.2

1.1

1.18

1.16

u/l

0.05

122

Certain infectious and parasitic diseases, including avohilmo

331

995

1.67

15.31

1.1

1.10

1.06

u/l

0.43

154

372

Asthma (diagnoses ohter than nonallergic)

423

2230

1.54

15.19

1.1

1.03

1.13

u/l

2.25

169

908

Panic disorder

106

454

2.35

15.08

1.1

1.00

1.09

u/l

1.20

173

Shoulder lesions

326

1185

1.65

15.08

1.0

1.1

1.10

1.14

u/l

0.36

130

486

Pain in thoracic spine

312

2.65

14.99

1.1

1.04

1.14

u/l

0.73

121

Non-follicular lymphoma

163

3.34

14.89

1.2

1.1

1.25

1.17

u/l

0.32

Ptosis of eyelid

204

3.07

14.83

1.2

1.0

1.00

1.22

u/l

2.37

Asthma, hospital admission 2, infections

284

1669

1.66

14.71

1.1

1.07

1.13

u/l

0.53

107

670

Asthma-related infections

284

1669

1.66

14.71

1.1

1.07

1.13

u/l

0.53

107

670

Other sleep disorders

205

3.05

14.70

1.1

1.0

1.19

1.13

u/l

0.18

Rotator cuff syndrome

256

1017

1.74

14.67

1.0

1.1

1.11

1.16

u/l

0.33

103

427

SLE (Finngen)

5.17

14.61

1.1

1.0

1.01

1.10

u/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

437

1886

1.52

14.52

1.1

1.17

1.09

u/l

0.77

188

734

Gastrointestinal diseases

310

930

1.68

14.52

1.1

1.04

1.15

u/l

1.13

119

382

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.71

14.48

1.1

0.94

1.14

u/l

2.33

Vocal cord dysfunction

246

2.73

14.43

1.0

1.1

1.22

1.14

u/l

0.15

107

Personality disorders, excluding more controls

145

715

2.03

14.41

1.1

1.17

1.09

u/l

0.32

278

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

439

2274

1.51

14.36

1.1

1.12

1.11

u/l

0.03

195

906

Chronic lower respiratory diseases

577

2106

1.45

14.30

1.1

1.08

1.12

u/l

0.53

224

863

Diseases of the respiratory system

300

897

1.68

14.23

1.1

1.09

1.16

u/l

0.55

116

368

Diseases of oesophagus, stomach and duodenum

500

2001

1.48

14.22

1.1

1.06

1.13

u/l

1.23

205

820

Hydrocephalus

115

3.78

14.22

1.1

1.0

1.93

1.17

u/l

1.39

Viral infections characterized by skin and mucous membrane lesions

211

1184

1.79

14.21

1.2

1.1

1.19

1.14

u/l

0.20

485

Coxibs

128

301

2.24

14.05

1.1

1.11

1.15

u/l

0.20

104

Chronic sinusitis

216

1224

1.77

14.05

1.1

1.02

1.14

u/l

1.78

102

494

Dissociative [conversion] disorders

108

3.86

13.91

1.0

1.1

1.11

1.08

u/l

0.09

Hypothyroidism, other/unspecified

421

1828

1.52

13.88

1.1

1.18

1.10

u/l

0.77

177

710

Cluster headache, strict

4.64

13.79

1.2

1.0

1.07

1.09

u/l

0.07

Endocrine, nutritional and metabolic diseases

399

1302

1.55

13.75

1.1

1.10

1.07

u/l

0.37

165

504

Nonorganic sleeping disorders, excluding more controls

115

532

2.17

13.64

1.1

1.01

1.11

u/l

1.26

208

Zoster [herpes zoster]

371

2.41

13.49

1.3

1.1

1.19

1.16

u/l

0.11

160

233

1357

1.71

13.44

1.1

1.05

1.13

u/l

0.73

521

Temporomandibular joint disorders, including avohilmo

268

1582

1.65

13.37

1.1

1.10

1.08

u/l

0.10

114

602

Cervicocranial syndrome

207

2.92

13.25

1.1

1.0

1.36

1.16

u/l

0.39

Abnormalities of heart beat

169

878

1.87

13.23

1.1

0.99

1.13

u/l

3.08

339

Neoplasms

404

1390

1.53

13.19

1.1

1.13

1.07

u/l

0.74

163

530

Enthesopathies of lower limb, excluding foot

107

488

2.20

13.16

1.1

1.06

1.13

u/l

0.50

193

Implicit fungal Sepsis, including avohilmo

136

3.42

13.15

1.3

1.1

1.05

1.18

u/l

0.91

Complications of medical and surgical care

337

1952

1.55

13.12

1.1

1.14

1.12

u/l

0.17

141

794

Cluster headache, wide

4.45

13.11

1.2

1.0

1.07

1.08

u/l

0.04

Benign paroxysmal vertigo

130

641

2.04

13.06

1.1

1.12

1.13

u/l

0.04

274

Complications of surgical and medical care, not elsewhere classified

458

2083

1.47

13.01

1.1

1.12

u/l

0.01

189

858

Bacterial infection, other or unspecified

218

1062

1.74

13.00

1.1

1.21

1.13

u/l

0.54

110

447

Non-allergic asthma (mode)

356

2.40

12.95

1.0

1.03

1.11

u/l

0.72

140

Other diseases of upper respiratory tract

480

1708

1.47

12.88

1.1

1.08

1.13

u/l

0.49

220

684

Other mental disorders due to brain damage and dysfunction and to physical disease

179

3.04

12.80

1.1

1.21

1.17

u/l

0.10

Myocarditis

3.90

12.80

1.3

1.1

1.09

u/l

-0.00

Traumatic subdural haemorrhage

5.45

12.75

1.2

1.0

1.56

1.23

u/l

—

Non-allergic asthma (mode), excluding more controls

360

2.38

12.65

1.0

1.03

1.11

u/l

0.72

144

Other disorders of central nervous system

9.69

12.62

1.1

1.0

1.16

1.05

u/l

0.47

Disorders of choroid and retina

324

1449

1.57

12.61

1.1

1.14

1.13

u/l

0.06

130

629

Acute upper respiratory infections

471

1940

1.46

12.60

1.1

1.06

1.13

u/l

0.76

172

803

Other functional intestinal disorders

202

1051

1.75

12.58

1.1

1.16

1.12

u/l

0.22

437

Hypermobility syndrome

172

3.07

12.44

1.0

1.1

1.05

1.06

u/l

0.05

Cramp and spasm

117

3.56

12.41

1.0

1.1

0.99

1.08

u/l

0.56

Cough

182

949

1.79

12.40

1.1

1.11

1.17

u/l

0.43

371

Osteopathies and chondropathies

246

1366

1.65

12.34

1.1

1.16

1.13

u/l

0.15

103

572

Hypertension, essential

371

1376

1.53

12.33

1.1

1.19

1.13

u/l

0.39

142

585

Restless leg syndrome

351

2.38

12.25

1.1

1.0

1.00

1.16

u/l

2.22

153

Functional dyspepsia

138

712

1.95

12.24

1.1

1.00

1.13

u/l

2.16

289

Bacterial infection, other or unspecified, including avohilmo

239

1180

1.66

12.16

1.1

1.21

1.12

u/l

0.61

118

490

Gastro-oesophageal reflux disease

306

1655

1.56

12.13

1.1

1.11

1.13

u/l

0.18

130

679

Acute sinusitis

280

1604

1.59

12.12

1.1

1.16

1.13

u/l

0.12

652

Dental pulpitis, including avohilmo

464

2064

1.44

11.94

1.1

1.10

1.12

u/l

0.19

173

844

Fall on same level

545

2065

1.41

11.92

1.1

1.10

1.11

u/l

0.13

219

830

Dentofacial anomalies [including malocclusion]

370

1939

1.50

11.87

1.1

1.07

1.11

u/l

0.38

155

754

Disorders of lipoprotein metabolism and other lipidaemias

333

1313

1.54

11.85

1.1

1.26

1.13

u/l

1.00

151

551

Spirochaetal infections, other/unspecified, including avohilmo

162

890

1.83

11.85

1.1

1.22

1.10

u/l

0.76

362

Brain glioblastoma and astrocytoma

5.98

11.85

1.0

1.1

1.42

1.03

u/l

0.56

Disorders of synovium and tendon

240

1239

1.65

11.84

1.1

1.05

1.14

u/l

1.15

494

Progressive vascular leukoencephalopathy

5.90

11.81

1.1

1.0

0.90

1.25

u/l

—

Non-selective monoamine reuptake inhibitors

142

717

1.91

11.79

1.0

1.1

1.12

1.13

u/l

0.06

294

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

471

2109

1.43

11.78

1.1

1.12

u/l

0.00

194

850

Benign neoplasms

468

1767

1.44

11.75

1.1

1.18

1.08

u/l

0.52

189

701

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

168

936

1.80

11.74

1.2

1.1

1.12

u/l

0.01

376

Other disorders of nervous system

117

3.45

11.66

1.3

1.0

0.99

1.13

u/l

1.09

Lesion of ulnar nerve

292

2.48

11.66

1.1

1.04

1.15

u/l

1.06

125

Anterior Iridocyclitis

108

520

2.09

11.65

1.2

1.1

1.19

1.12

u/l

0.22

219

Other spirochaetal diseases, including avohilmo

163

903

1.81

11.62

1.1

1.22

1.10

u/l

0.76

367

External causes of morbidity and mortality

312

995

1.58

11.60

1.1

1.08

1.14

u/l

0.46

130

391

Urinary track infection

304

964

1.58

11.56

1.1

1.10

1.08

u/l

0.17

121

373

Other medical care

188

905

1.75

11.54

1.1

1.51

1.07

u/l

1.77

102

379

Other spirochaetal diseases

161

892

1.81

11.48

1.1

1.23

1.10

u/l

0.78

361

Hypo-osmolality and hyponatraemia

274

2.51

11.45

1.1

1.25

1.14

u/l

0.32

123

Use of dimethyl fumarate

10.17

11.43

1.0

1.1

0.90

1.08

u/l

—

Disorders of the thyroid gland

434

1949

1.45

11.41

1.1

1.19

1.10

u/l

0.86

183

765

Sleep apnoea

417

1807

1.46

11.32

1.1

1.19

1.12

u/l

0.32

173

741

Other diseases of intestines

506

2001

1.41

11.28

1.1

1.01

1.13

u/l

3.39

189

821

Lyme disease

159

883

1.81

11.26

1.1

1.23

1.10

u/l

0.81

362

Lyme disease, including avohilmo

159

883

1.81

11.26

1.1

1.23

1.10

u/l

0.81

362

Complications of procedures, not elsewhere classified

367

2002

1.48

11.23

1.1

1.10

1.12

u/l

0.11

153

826

Hypopituitarism

183

2.87

11.16

1.2

1.1

1.19

1.06

u/l

0.34

Other arthritis (FG)

144

778

1.86

11.14

1.1

1.17

1.09

u/l

0.44

308

Chronic iridocyclitis

116

3.41

11.11

1.2

1.1

1.24

1.08

u/l

0.29

Obesity related asthma

165

931

1.78

11.08

1.1

1.03

1.12

u/l

1.09

373

Pure hypercholesterolaemia

288

1171

1.56

10.98

1.1

1.31

1.14

u/l

1.28

135

503

Other external causes of accidental injury

371

1246

1.49

10.94

1.1

1.07

1.14

u/l

0.93

148

496

Undetermined asthma

242

2.57

10.87

1.1

1.0

1.10

1.15

u/l

0.18

Other and unspecified types of non-Hodgkin lymphoma, hilmo

4.23

10.83

1.3

1.0

1.61

1.14

u/l

0.90

Hypertensive diseases

372

1418

1.48

10.82

1.1

1.16

1.13

u/l

0.21

136

599

Rheumatism, unspecified

249

2.55

10.79

1.1

1.10

1.18

u/l

0.24

108

Arthropathies

438

1540

1.44

10.73

1.1

1.08

1.11

u/l

0.26

180

608

Other specified/unspecified arthritis

129

683

1.90

10.66

1.1

1.18

1.08

u/l

0.56

268

Speech and linguistic disorders, excluding more controls

181

2.77

10.54

1.1

1.0

1.21

1.05

u/l

0.58

Sleep disorders (combined)

487

1813

1.41

10.52

1.1

1.05

1.10

u/l

0.86

185

757

Hypertension

370

1418

1.47

10.49

1.1

1.17

1.13

u/l

0.21

135

599

Acute upper respiratory infections of multiple and unspecified sites

361

1804

1.46

10.30

1.1

0.99

1.14

u/l

4.08

140

740

Undetermined asthma, excluding more controls

249

2.50

10.27

1.1

1.0

1.10

1.14

u/l

0.15

Genitourinary diseases

253

792

1.61

10.26

1.1

1.05

1.13

u/l

0.86

108

350

Voice disturbances

125

664

1.89

10.25

1.0

1.1

1.03

1.13

u/l

1.31

268

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

264

1680

1.54

10.24

1.0

1.1

1.16

1.12

u/l

0.22

113

678

Other heart diseases

232

937

1.61

10.15

1.1

1.12

1.13

u/l

0.00

372

Accidents

366

1246

1.47

10.14

1.1

1.06

1.14

u/l

1.14

147

496

Chronic diseases of tonsils and adenoids

368

1594

1.46

10.12

1.1

1.10

1.13

u/l

0.31

144

635

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

171

1002

1.71

10.12

1.1

1.07

1.10

u/l

0.21

383

Dermatitis and eczema

504

2164

1.38

10.09

1.1

1.12

1.11

u/l

0.05

210

880

All influenza

118

619

1.91

10.05

1.1

1.03

1.09

u/l

0.32

260

Intracranial injury

259

1565

1.55

10.03

1.1

1.18

1.12

u/l

0.26

103

639

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

145

2.99

9.99

1.0

1.1

1.09

1.15

u/l

0.21

Carpal tunnel syndrome

241

1331

1.57

9.96

1.1

1.09

1.15

u/l

0.60

514

Other disorders of eyelid

151

808

1.77

9.91

1.1

1.11

1.17

u/l

0.37

342

Viral meningitis, including avohilmo

110

3.33

9.88

1.2

1.0

1.13

1.07

u/l

0.24

Zoster [herpes zoster], including avohilmo

204

1213

1.63

9.88

1.2

1.1

1.13

1.11

u/l

0.13

500

Fasciculation

10.96

9.86

1.0

1.1

0.98

1.19

u/l

—

Asthma, hospital admissions , main diagnosis only

372

2266

1.43

9.73

1.1

1.02

1.13

u/l

2.58

147

920

Acute and subacute iridocyclitis

490

2.01

9.63

1.2

1.1

1.21

1.12

u/l

0.24

201

Fourth [trochlear] nerve palsy

4.87

9.57

1.0

1.32

1.13

u/l

—

Constipation

372

1760

1.43

9.52

1.1

1.23

1.11

u/l

1.02

151

724

Acetic acid derivatives and related substances

113

293

2.00

9.51

1.1

1.09

1.16

u/l

0.33

100

Benign neoplasm of brain and other parts of central nervous system

139

2.98

9.46

1.1

1.23

1.18

u/l

0.09

Other shoulder lesions

206

2.59

9.45

1.1

1.17

1.13

u/l

0.10

Dental caries

118

595

1.88

9.44

1.1

1.22

1.11

u/l

0.32

263

Falls/tendency to fall

490

1790

1.37

9.24

1.1

1.08

1.11

u/l

0.35

200

714

Caries of dentine

105

526

1.93

9.19

1.1

1.24

1.09

u/l

0.43

235

Other disorders of bladder

204

2.56

9.11

1.2

1.1

1.04

1.14

u/l

0.43

Other disorders of optic disc

7.24

9.10

1.1

1.0

0.97

1.08

u/l

—

Nystagmus and other irregular eye movements

7.23

9.10

1.1

1.0

1.47

1.13

u/l

0.27

Other specified/unspecified systemic involvement of connective tissue

121

3.09

9.10

1.2

1.1

1.33

1.10

u/l

0.43

Cardiac arrhythmias

290

1247

1.49

9.07

1.1

1.05

1.14

u/l

1.05

115

510

Disorders of muscles

205

2.55

9.03

1.1

1.0

1.02

1.13

u/l

0.96

Retinal detachments and breaks

126

700

1.81

9.01

1.1

1.01

1.12

u/l

2.17

310

Urticaria and erythema

186

1150

1.62

9.00

1.1

1.17

1.10

u/l

0.36

454

Use of pramipexole

435

2.03

8.95

1.1

0.99

1.15

u/l

2.48

191

Viral meningitis

107

3.23

8.93

1.2

1.0

1.13

1.06

u/l

0.29

Algoneurodystrophy

3.43

8.93

1.0

1.1

1.24

1.07

u/l

0.70

Other/unspecified enthesopathies of lower limb, excluding foot

150

2.82

8.84

1.1

0.99

1.16

u/l

0.96

Unknown and unspecified causes of morbidity

113

3.12

8.78

1.2

1.0

1.04

1.13

u/l

0.41

Sleep apnoea, including avohilmo

430

1885

1.38

8.75

1.1

1.06

1.11

u/l

0.93

178

770

Pain and other conditions associated with female genital organs and menstrual cycle

130

611

1.79

8.70

1.1

1.04

1.07

u/l

0.20

234

Asthma, hospital admissions 3, pneumonia

140

808

1.73

8.69

1.1

1.16

1.11

u/l

0.20

322

Asthma-related pneumonia or sepsis

140

808

1.73

8.69

1.1

1.16

1.11

u/l

0.20

322

Other and unspecified mononeuropathies, also in other diseases

4.29

8.68

1.1

1.01

1.15

u/l

0.96

Explicit Sepsis, including avohilmo

166

909

1.66

8.68

1.1

1.16

1.15

u/l

0.09

367

Systemic lupus erythematosus

3.42

8.65

1.1

1.01

1.10

u/l

—

Myopia

394

2.07

8.64

1.1

1.01

1.06

u/l

0.35

152

COPD/asthma/ILD related infections

449

1636

1.38

8.64

1.1

1.14

1.13

u/l

0.09

170

678

COPD/asthma related infections

449

1636

1.38

8.64

1.1

1.14

1.13

u/l

0.09

170

678

Cauda equina syndrome

7.13

8.62

1.1

1.0

1.23

1.13

u/l

—

Hypermetropia

158

2.74

8.58

1.1

1.30

1.14

u/l

0.23

Abnormal findings on examination of blood, without diagnosis

180

1009

1.62

8.53

1.1

1.07

1.13

u/l

0.63

438

Other/unspecified disorders of vestibular function

3.45

8.51

1.0

1.04

1.15

u/l

—

Other and unspecified paralytic syndromes

7.53

8.51

1.0

1.15

1.09

u/l

—

Unspecified/other endometriosis

317

2.18

8.50

1.0

1.1

0.87

1.06

u/l

5.55

114

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

238

1575

1.51

8.47

1.1

1.16

1.12

u/l

0.16

100

631

Asthma-related pneumonia

139

807

1.72

8.47

1.1

1.16

1.11

u/l

0.20

322

Respiratory insufficiency

3.42

8.44

1.1

1.0

0.97

1.28

u/l

1.49

Other bacterial diseases

387

1843

1.39

8.42

1.1

1.21

1.12

u/l

0.92

176

736

Chronic rhinitis, nasopharyngitis and pharyngitis

155

932

1.67

8.41

1.2

1.1

1.15

1.11

u/l

0.22

356

Other enthesopathies

127

724

1.76

8.36

1.1

1.08

1.18

u/l

0.70

283

Alzheimer’s disease (Early onset)

4.00

8.33

1.1

1.0

1.00

1.21

u/l

1.02

Disorders of mineral metabolism

178

2.60

8.33

1.1

0.94

1.14

u/l

2.60

Bacterial meningitis

3.56

8.27

1.2

1.1

1.60

1.09

u/l

—

Explicit Sepsis

161

891

1.65

8.26

1.1

1.17

1.15

u/l

0.14

358

Other specified/unspecified necrotizing vasculopathies

7.73

8.22

1.1

1.0

1.16

1.15

u/l

—

Postviral fatigue syndrome

8.45

8.18

1.2

1.0

0.94

1.02

u/l

—

Other disorders of bone

102

549

1.87

8.14

1.0

1.1

1.09

1.10

u/l

0.06

224

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

388

1636

1.39

8.13

1.1

1.20

1.13

u/l

0.50

148

678

388

1636

1.39

8.13

1.1

1.20

1.13

u/l

0.50

148

678

Intestinal infectious diseases, including avohilmo, including avohilmo

499

2083

1.34

8.12

1.1

1.10

1.12

u/l

0.11

210

843

SLE, strict definition

3.35

8.09

1.1

1.01

1.11

u/l

—

SLE, ICD10

3.35

8.09

1.1

1.01

1.11

u/l

—

Generalized anxiety disorder

521

1.89

8.09

1.1

0.96

1.09

u/l

1.64

199

Other skin changes

360

2.06

7.91

1.1

1.05

1.14

u/l

0.49

153

Persons with potential health hazards related to communicable diseases

208

1350

1.53

7.91

1.1

1.07

1.09

u/l

0.23

529

Immunodeficiency with predominantly antibody defects

3.99

7.91

1.2

1.1

1.03

1.09

u/l

—

Disorders of conjunctiva

382

2159

1.37

7.86

1.1

1.12

1.11

u/l

0.08

155

860

Influenza and pneumonia

473

2190

1.33

7.80

1.1

1.19

1.10

u/l

0.80

180

898

Conjunctivitis (acute, non atopic), including avohilmo

438

1961

1.35

7.80

1.1

1.11

u/l

0.01

185

797

Cluster headache, strict, including avohilmo

145

2.72

7.68

1.2

1.1

1.06

1.08

u/l

0.11

Bronchitis

478

2160

1.33

7.65

1.1

1.02

1.13

u/l

2.66

182

893

Diarrhoea and gastroenteritis of presumed infectious origin

318

2028

1.40

7.60

1.1

1.12

1.11

u/l

0.09

130

827

Other and unspecified mononeuropathies of upper limb

3.84

7.54

1.1

1.05

1.14

u/l

0.55

Injuries to the neck

122

712

1.72

7.47

1.1

1.18

1.08

u/l

0.30

288

479

1829

1.33

7.45

1.1

1.07

1.14

u/l

0.78

179

760

Spondyloarthritis

389

1.99

7.45

1.1

1.37

1.12

u/l

0.75

174

Soft tissue disorders related to use, overuse and pressure

105

587

1.79

7.45

1.1

1.26

1.17

u/l

0.26

249

Infections with a predominantly sexual mode of transmission, including avohilmo

227

1401

1.49

7.44

1.1

1.02

1.09

u/l

1.16

541

Disorders of lens

237

987

1.49

7.43

1.1

1.16

u/l

0.00

465

Systemic lupus erythematosus, unspecified

3.31

7.41

1.0

1.03

1.10

u/l

—

Other symptoms and signs involving the digestive system and abdomen

343

2.05

7.37

1.1

1.14

1.17

u/l

0.12

148

Disorders of calcium metabolism

120

2.86

7.37

1.1

1.0

0.95

1.17

u/l

2.11

Other bacterial diseases, including avohilmo

429

2003

1.34

7.29

1.1

1.21

1.10

u/l

1.14

191

796

Disturbances of smell and taste

3.41

7.26

1.1

1.10

1.17

u/l

—

Chronic apical periodontitis

493

2110

1.31

7.15

1.1

1.08

1.12

u/l

0.38

181

863

Conjunctivitis

351

2069

1.37

7.15

1.1

1.10

1.11

u/l

0.05

139

816

Hypokalaemia

223

2.30

7.15

1.2

1.1

0.99

1.13

u/l

1.61

100

Other viral diseases, including avohilmo

197

1293

1.51

7.14

1.1

1.15

1.09

u/l

0.24

501

Cluster headache, wide,, including avohilmo

151

2.61

7.12

1.2

1.1

1.06

1.08

u/l

0.10

Fungal Sepsis

3.37

7.11

1.2

1.0

1.13

1.16

u/l

—

Inflammatory diseases of female pelvic organs

304

1484

1.40

7.09

1.0

1.1

1.11

1.09

u/l

0.09

108

576

Other peripheral vascular diseases

187

2.42

7.08

1.0

1.1

1.03

1.14

u/l

1.10

Diseases of pulp and periapical tissues, including avohilmo

443

1722

1.33

7.06

1.1

1.06

1.13

u/l

1.04

157

707

Diseases of the skin and subcutaneous tissue

422

1579

1.34

7.05

1.1

1.04

1.13

u/l

1.49

162

657

Specific development disorders of speech and language

140

2.64

7.05

1.1

1.31

0.98

u/l

1.11

Septicaemia

148

838

1.61

7.04

1.1

1.19

1.12

u/l

0.47

338

Drug-induced cataract

4.25

7.03

1.3

1.0

0.93

1.12

u/l

—

Intestinal infectious diseases

411

2294

1.33

7.03

1.1

1.10

1.12

u/l

0.18

170

930

Benign neoplasm: Brain, supratentorial

5.95

6.96

1.1

1.35

1.12

u/l

0.26

Other and unspecified hydrocephalus

5.55

6.95

1.2

1.0

1.69

1.10

u/l

—

Metatarsalgia

195

2.37

6.93

1.0

1.1

1.02

1.17

u/l

1.40

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

3.02

6.93

1.1

0.92

1.11

u/l

2.54

Hyperkinetic disorders, excluding more controls

392

1.91

6.88

1.0

1.1

1.16

1.03

u/l

0.26

146

Disorders of adult personality and behaviour

156

993

1.58

6.83

1.1

1.18

1.07

u/l

0.52

386

Other septicaemia

130

744

1.65

6.83

1.1

1.14

1.07

u/l

0.83

300

Deforming dorsopathies

105

603

1.75

6.83

1.0

1.1

1.08

1.11

u/l

0.25

238

Herpesviral [herpes simplex] infections

293

2.09

6.82

1.2

1.0

1.08

1.15

u/l

0.29

127

Deviated nasal septum

129

783

1.65

6.82

1.1

1.02

1.17

u/l

1.60

333

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

155

974

1.58

6.81

1.1

1.02

1.10

u/l

0.94

375

Trochanteric bursitis

267

2.14

6.79

1.0

1.1

1.33

1.18

u/l

0.28

117

Phobic anxiety disorders

402

1.92

6.78

1.1

0.99

1.06

u/l

0.61

158

Injuries to the wrist and hand

445

2249

1.31

6.74

1.1

1.06

1.12

u/l

0.81

175

919

Other respiratory disorders and diseases

355

1.98

6.74

1.1

1.22

1.14

u/l

0.16

160

Other diseases of the respiratory system

355

1.98

6.74

1.1

1.22

1.14

u/l

0.16

160

Other septicaemia, including avohilmo

133

765

1.64

6.73

1.1

1.13

1.07

u/l

0.63

306

Mycoses

124

749

1.66

6.72

1.2

1.1

1.17

1.09

u/l

0.41

288

Benign neoplasm: Pituitary gland, craniopharyngeal duct

138

2.64

6.72

1.1

1.0

1.33

1.10

u/l

0.40

Other disorders of ear

375

1802

1.35

6.72

1.1

1.13

1.14

u/l

0.09

152

742

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

203

852

1.50

6.71

1.1

1.12

u/l

0.00

337

Implicit fungal Sepsis

3.32

6.70

1.2

1.0

1.13

u/l

—

Candidiasis, including avohilmo

144

904

1.60

6.69

1.2

1.1

1.12

1.09

u/l

0.14

345

Ovarian cyst

175

643

1.56

6.69

1.1

1.01

1.08

u/l

1.11

252

Kela reimbursement Agammaglobulinemia (D80-84)

8.07

6.68

1.4

1.1

0.96

1.16

u/l

—

Propionic acid derivatives

109

308

1.78

6.68

1.1

1.07

1.18

u/l

0.66

106

Anti-inflammatory and antirheumatic products, non-steroids

109

308

1.78

6.67

1.0

1.1

1.04

1.18

u/l

1.01

106

Degenerative diseases of the nervous system

372

1.82

6.67

1.1

1.02

1.15

u/l

1.91

169

Hypothyroidism, strict autoimmune, 3 medication purchases required

354

1758

1.35

6.65

1.1

1.19

1.07

u/l

1.33

151

679

Temporal arteritis

3.74

6.65

1.4

1.1

1.17

1.20

u/l

0.04

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

207

875

1.50

6.62

1.0

1.1

0.99

1.05

u/l

1.15

301

Disorders of pituitary gland, other and/or unspecified

10.49

6.62

1.3

1.1

1.16

1.02

u/l

—

Early lumbar disc prolapse, operated

257

2.15

6.61

1.1

1.05

1.04

u/l

0.09

Glaucoma suspect

124

752

1.65

6.61

1.1

1.04

1.11

u/l

1.05

334

Persons encountering health services in other circumstances

176

1147

1.52

6.60

1.1

1.00

1.10

u/l

1.85

458

Injuries to the knee and lower leg

514

2157

1.29

6.58

1.1

1.08

1.12

u/l

0.46

219

861

Other metabolic disorders

352

1.97

6.56

1.2

1.1

1.19

1.10

u/l

0.16

135

Hereditary ataxia

6.99

6.56

1.0

0.96

1.01

u/l

—

Polyarteritis nodosa and related conditions

6.98

6.55

1.0

1.28

1.11

u/l

—

Speech and linguistic disorders

234

2.18

6.55

1.1

1.21

1.06

u/l

0.49

Injury, poisoning and certain other consequences of external causes

240

826

1.46

6.53

1.1

1.08

1.15

u/l

0.54

100

323

Other enthesopathy of foot (+metatarsalgia)

220

2.24

6.50

1.0

1.1

1.01

1.17

u/l

1.72

Giant cell arteritis with polymyalgia rheumatica

3.67

6.48

1.4

1.1

1.17

1.20

u/l

0.04

Paracetamol or NSAID medication

162

2.09

6.46

1.0

1.06

1.20

u/l

0.51

Mycoses, including avohilmo

402

2322

1.32

6.46

1.1

1.05

1.13

u/l

1.37

179

924

Any dementia, excluding more controls

363

1.80

6.45

1.1

1.08

1.12

u/l

0.26

158

Persistent mood disorders

468

1.82

6.41

1.1

1.20

1.14

u/l

0.23

188

Other nutritional deficiencies

309

2070

1.37

6.41

1.1

1.21

1.09

u/l

0.38

117

837

Paroxysmal tachycardia

447

1.77

6.33

1.1

1.06

1.19

u/l

0.64

188

Behavioural syndromes associated with physiological disturbances and physical factors

410

2113

1.31

6.31

1.1

1.11

u/l

0.06

156

874

Disorders of vitreous body

173

1090

1.51

6.30

1.1

1.18

1.13

u/l

0.18

483

Disorders of vitreous body and globe

177

1115

1.50

6.27

1.1

1.18

1.12

u/l

0.20

493

Benign neoplasm of other and unspecified endocrine glands

303

2.02

6.27

1.1

1.26

1.17

u/l

0.20

141

Exposure to unspecified factor

438

2293

1.30

6.25

1.1

1.11

1.12

u/l

0.08

192

917

Transport accidents

208

1188

1.46

6.25

1.1

1.13

1.14

u/l

0.05

475

Urticaria

147

944

1.56

6.23

1.1

1.19

1.12

u/l

0.25

379

Sleep disorders

399

2090

1.32

6.23

1.1

1.12

1.11

u/l

0.06

147

862

Contact with and exposure to communicable diseases

170

1124

1.51

6.18

1.1

1.03

1.06

u/l

0.25

439

Other symptoms and signs involving the circulatory and respiratory systems

144

2.52

6.18

1.1

1.05

1.13

u/l

0.53

Exclusions for E4_PCOS_CONSORTIUM

337

1560

1.35

6.16

1.1

1.08

1.09

u/l

0.10

141

608

Other heart diseases, wide

418

1935

1.31

6.14

1.1

1.11

1.13

u/l

0.16

171

799

Any death

208

997

1.46

6.12

1.1

1.43

1.08

u/l

1.25

445

Scleritis and episcleritis

151

2.47

6.11

1.1

1.04

1.08

u/l

0.20

Myositis

3.80

6.10

1.0

0.99

1.28

u/l

—

Other complications of surgical and medical care, not elsewhere classified

227

2.17

6.05

1.2

1.1

1.27

1.15

u/l

0.16

101

Other viral diseases

145

932

1.56

6.04

1.1

1.20

1.07

u/l

0.45

371

Other obstetric conditions, not elsewhere classified

209

905

1.46

6.03

1.0

1.1

1.00

1.05

u/l

0.59

313

Dislocation, sprain and strain of joints and ligaments at neck level

515

1.76

6.01

1.1

1.07

1.06

u/l

0.09

203

Giant cell arteritis

3.27

6.01

1.4

1.0

1.18

1.16

u/l

0.03

Other specified/unspecified inflammatory spondylopathies

100

2.82

6.00

1.2

1.1

1.56

1.08

u/l

0.67

Other diseases of blood and blood-forming organs, wide

508

1.76

5.99

1.1

1.08

1.14

u/l

0.65

216

Infections with a predominantly sexual mode of transmission

170

1138

1.50

5.92

1.1

1.04

1.08

u/l

0.35

451

Use of amantadine

5.11

5.91

1.0

1.1

1.16

1.14

u/l

—

Personality disorders

145

941

1.55

5.90

1.1

1.17

1.07

u/l

0.41

366

Tinnitus

585

1.70

5.89

1.1

1.07

1.12

u/l

0.47

252

Other and unspecified spinal muscular atrophies

8.27

5.89

1.2

1.1

1.12

1.02

u/l

—

Dystonia

124

2.60

5.88

1.1

1.03

1.11

u/l

0.48

Brain glioblastoma

5.90

5.87

1.0

1.14

1.05

u/l

—

Oxicams

244

1.87

5.87

1.1

1.22

1.19

u/l

0.08

Benign neoplasm of colon, rectum, anus and anal canal

207

1216

1.44

5.86

1.2

1.1

1.26

1.13

u/l

0.39

105

520

Faecal incontinence

148

2.44

5.85

1.3

1.1

0.98

1.21

u/l

1.31

Plantar fascial fibromatosis

192

2.25

5.81

1.1

1.05

1.18

u/l

0.95

Acute bronchitis

160

1044

1.51

5.78

1.1

1.07

1.09

u/l

0.13

422

Vascular dementia

2.95

5.78

1.1

1.0

1.30

1.23

u/l

—

Other specified disorders of muscle

3.64

5.77

1.1

1.0

0.99

1.08

u/l

—

Social phobias

265

2.05

5.76

1.0

1.1

0.99

1.02

u/l

0.16

105

Dermatographic urticaria

193

2.25

5.76

1.1

1.09

1.10

u/l

0.03

Reimbursement for rheumatic diseases

227

1608

1.41

5.72

1.1

1.21

1.11

u/l

0.64

659

Asthma/COPD (KELA code 203)

408

2105

1.30

5.72

1.1

1.08

1.12

u/l

0.37

162

863

Vertigo of central origin

5.66

5.71

1.1

1.0

1.26

1.12

u/l

—

Raynaud syndrome

253

2.07

5.70

1.0

1.1

1.01

1.13

u/l

1.33

106

Disorders of speech understanding and production

2.86

5.68

1.2

1.0

1.35

1.10

u/l

0.47

Nonorganic sleeping disorders

115

715

1.61

5.65

1.1

1.01

1.09

u/l

0.98

284

Astigmatism

151

2.40

5.61

1.1

0.96

1.08

u/l

1.38

Brain glioblastoma, helper endpoint

5.48

5.57

1.0

1.14

u/l

—

All kidney diseases

418

2178

1.29

5.56

1.1

1.15

1.11

u/l

0.33

158

902

Spondylolisthesis/Spondylolysis

338

1.90

5.55

1.0

1.1

1.11

1.15

u/l

0.14

140

Injuries to the ankle and foot

335

2172

1.32

5.54

1.1

1.03

1.12

u/l

1.68

131

874

Glaucoma

175

1014

1.47

5.49

1.1

1.22

1.11

u/l

0.49

447

Other and unspecified coagulation defects

141

2.43

5.46

1.1

1.00

1.08

u/l

0.77

Insomnia

391

2107

1.29

5.42

1.1

1.13

1.11

u/l

0.14

143

868

Panhypopituitarism

5.26

5.41

1.1

1.0

1.53

1.11

u/l

—

Coagulation defects, purpura and other haemorrhagic conditions

495

1.72

5.38

1.1

1.09

1.15

u/l

0.43

200

Endometriosis of pelvic peritoneum

462

1.72

5.37

1.0

1.1

0.93

1.07

u/l

2.56

180

Herpesviral [herpes simplex] infections, including avohilmo

126

811

1.56

5.37

1.1

1.14

u/l

0.02

317

Other arrhythmias

273

1506

1.36

5.34

1.1

1.07

1.13

u/l

0.70

113

614

Specific personality disorders

125

805

1.56

5.32

1.1

1.16

1.07

u/l

0.32

308

Injuries to the head

475

2235

1.26

5.31

1.1

1.14

1.11

u/l

0.25

197

904

Rash and other nonspecific skin eruption

187

2.20

5.30

1.0

1.1

1.01

1.10

u/l

0.59

Sequelae of external causes of morbidity and mortality

100

612

1.64

5.26

1.1

1.26

1.11

u/l

0.48

248

Covid-19 suspected case

108

674

1.61

5.26

1.1

1.10

1.06

u/l

0.23

246

Diabetic neuropathy

194

2.16

5.20

1.1

1.29

1.07

u/l

0.23

Other abnormal immunological findings in serum

3.52

5.19

1.0

1.1

0.97

1.10

u/l

—

Bipolar affective disorders

561

1.66

5.19

1.0

1.1

0.99

1.11

u/l

1.16

214

Keratitis

151

1022

1.48

5.10

1.1

1.13

1.10

u/l

0.15

409

Benign neoplasm: Colon

169

1095

1.45

5.09

1.2

1.1

1.28

1.13

u/l

0.37

488

Episcleritis

134

2.41

5.06

1.1

1.05

1.06

u/l

0.05

Polymyalgia rheumatica

191

2.15

5.05

1.1

1.04

1.21

u/l

1.35

Irregular menses

250

1383

1.36

5.04

1.1

0.98

1.11

u/l

4.14

102

517

Any dementia

401

1.66

5.00

1.1

1.08

1.15

u/l

0.51

189

Pneumonia, organism unspecified

376

2010

1.28

4.98

1.1

1.23

1.11

u/l

1.09

143

832

Abnormal results of function studies

199

2.12

4.97

1.0

1.1

1.30

1.13

u/l

0.23

Appendectomy

287

2068

1.32

4.97

1.1

1.05

1.12

u/l

0.66

856

Circumscribed brain atrophy

5.07

4.95

1.0

1.00

1.12

u/l

—

Ankylosing spondylitis

167

2.23

4.93

1.1

1.45

1.07

u/l

0.64

3.15

4.93

1.0

1.00

1.10

u/l

—

Alzheimer’s disease (Late onset), excluding more controls

3.25

4.90

1.2

1.1

1.11

1.32

u/l

—

Disorders of skin appendages

228

1666

1.36

4.88

1.1

0.98

1.10

u/l

2.95

654

Acute tubulo-interstitial nephritis

244

1524

1.35

4.86

1.1

1.13

1.10

u/l

0.16

614

Horner syndrome

4.94

4.84

1.1

1.0

1.34

1.15

u/l

—

Other and unspecified trigeminal disorders

4.91

4.83

1.1

0.98

1.15

u/l

—

Osteoporosis with pathological fracture (FG)

2.64

4.81

1.2

1.0

1.03

1.15

u/l

0.43

Conjunctivitis (acute, non atopic)

125

821

1.52

4.80

1.1

1.16

1.08

u/l

0.33

320

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

413

2179

1.26

4.79

1.1

1.23

1.10

u/l

1.29

161

898

Diabetes insipidus

5.88

4.79

1.0

1.72

1.04

u/l

—

Osteoporosis

441

1.69

4.79

1.2

1.1

1.17

1.14

u/l

0.07

203

Emotionally unstable personality disorder

445

1.72

4.78

1.1

1.03

1.04

u/l

0.04

171

Allergic asthma (mode)

101

620

1.59

4.77

1.1

1.0

0.98

1.09

u/l

1.52

230

Endometriosis

157

621

1.47

4.76

1.0

1.1

1.02

1.09

u/l

0.49

246

Localized swelling, mass and lump of skin and subcutaneous tissue

110

708

1.56

4.73

1.1

1.10

u/l

0.02

293

Sacroiliitis, not elsewhere classified

126

2.40

4.73

1.2

1.1

1.63

1.05

u/l

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

329

1.83

4.71

1.2

1.1

1.17

1.12

u/l

0.09

125

Allergic asthma (mode), excluding more controls

101

623

1.59

4.68

1.1

1.0

0.98

1.10

u/l

1.64

230

Other diseases of arteries and capillaries

184

2.13

4.68

1.1

1.11

1.16

u/l

0.16

Other disorders of skin and subcutaneous tissue

272

1738

1.32

4.66

1.1

1.17

1.13

u/l

0.20

114

715

Procreative management

162

928

1.44

4.66

1.1

1.05

1.13

u/l

1.09

369

Attention to artificial openings

3.13

4.64

1.2

1.1

1.57

1.10

u/l

—

Disorders of orbit

103

2.55

4.63

1.2

1.0

0.97

1.08

u/l

—

Polyarthropathies

269

1300

1.33

4.62

1.1

1.22

1.13

u/l

0.59

108

520

Adrenocortical insufficiency

2.78

4.62

1.5

1.1

1.16

1.04

u/l

0.44

Dementia

107

464

1.58

4.62

1.1

1.07

1.13

u/l

0.55

220

Meralgia paraesthetica

2.93

4.61

1.0

1.1

1.10

1.06

u/l

—

Special screening examination for other diseases and disorders

205

2.05

4.61

1.1

1.0

0.98

1.10

u/l

0.98

105

Other symptoms and signs involving general sensations and perceptions

2.92

4.60

1.2

1.0

1.00

1.10

u/l

—

Spondylopathies (FG)

383

1.76

4.59

1.1

1.42

1.09

u/l

0.94

145

Senile cataract

191

827

1.41

4.58

1.1

1.13

1.17

u/l

0.15

400

Other peripheral vertigo

193

2.08

4.55

1.2

1.0

1.06

1.18

u/l

0.78

100

Arthropathies in other diseases classified elsewhere

2.74

4.52

1.5

1.0

1.39

1.14

u/l

—

Diseases of salivary glands

135

918

1.47

4.51

1.1

1.07

1.12

u/l

0.47

368

Anomalies of pupillary function

3.19

4.50

1.1

1.33

1.12

u/l

—

Bleeding

291

1562

1.31

4.50

1.1

1.20

1.13

u/l

0.44

123

663

Complications of other internal prosthetic devices, implants and grafts

2.88

4.50

1.2

1.1

1.31

1.22

u/l

—

Vestibular neuronitis

194

2.07

4.49

1.0

1.1

1.24

1.16

u/l

0.10

Secondary and unspecified malignant neoplasm of lymph nodes

161

2.19

4.49

1.1

1.11

1.18

u/l

0.23

Pneumonias (Asthma/COPD co-morbidities)

421

2203

1.25

4.46

1.1

1.23

1.10

u/l

1.27

161

907

Vertical strabismus

2.79

4.46

1.1

1.11

1.07

u/l

—

Focal brain injury

5.23

4.45

1.2

1.0

1.83

1.32

u/l

—

Nontraumatic intracranial haemmorrhage

299

1.84

4.44

1.0

1.1

1.44

1.15

u/l

0.69

141

Divergent concomitant strabismus

175

2.13

4.44

1.1

1.26

1.11

u/l

0.44

Presence of other functional implants

182

889

1.40

4.43

1.2

1.1

1.13

1.14

u/l

0.04

399

Substance abuse, excluding more controls

199

1211

1.37

4.43

1.1

1.14

u/l

0.01

512

Persons encountering health services for specific procedures, not carried out

216

2.00

4.40

1.0

1.1

1.20

1.06

u/l

0.50

Other and unspecified erythematous conditions

2.85

4.40

1.1

0.98

1.10

u/l

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

223

1.98

4.39

1.2

1.1

1.09

1.14

u/l

0.22

100

Bacterial pneumonia, not elsewhere classified

133

794

1.47

4.37

1.1

1.21

1.10

u/l

0.74

332

Other viral diseases, not elsewhere classified, including avohilmo

127

854

1.48

4.36

1.1

1.05

1.09

u/l

0.33

340

Poisoning by drugs, medicaments and biological substances

117

779

1.51

4.36

1.1

1.09

1.07

u/l

0.12

308

Intracerebral haemorrhage

163

2.15

4.35

1.1

1.14

1.18

u/l

0.18

Other erythematous conditions

2.68

4.33

1.0

1.1

0.99

1.09

u/l

—

All pneumoniae

422

2206

1.24

4.32

1.1

1.22

1.10

u/l

1.25

164

906

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

118

789

1.50

4.32

1.1

1.00

1.05

u/l

0.66

297

Aneurysms, operations, SAH

295

1.84

4.31

1.0

1.1

1.52

1.16

u/l

0.57

137

Diseases of male genital organs

172

609

1.42

4.31

1.1

1.17

1.16

u/l

0.02

270

Dementia, including avohilmo

116

521

1.52

4.27

1.1

1.09

1.15

u/l

0.47

238

Other and unspecified myopathies

158

2.16

4.27

1.1

1.33

1.19

u/l

0.16

Fenamates

202

1.86

4.26

1.1

1.04

1.24

u/l

1.04

Intermittent heterotropia

145

2.22

4.25

1.0

1.49

1.05

u/l

0.71

Chronic laryngitis and laryngotracheitis

297

1.82

4.23

1.1

1.23

1.21

u/l

0.03

121

Sleep disorders, other/unspecified

108

2.43

4.23

1.2

1.1

0.95

1.09

u/l

0.91

Other specified/unspecified hearing loss

172

2.10

4.22

1.1

1.23

1.20

u/l

0.07

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

265

1575

1.31

4.21

1.1

1.11

1.10

u/l

0.07

108

609

Other CVD (FINNGEN)

149

2.05

4.20

1.2

1.1

1.37

1.10

u/l

0.65

Drug-induced adrenocortical insufficiency

3.46

4.20

1.5

1.0

1.14

u/l

—

Fibroblastic disorders

401

1.70

4.20

1.1

1.08

1.13

u/l

0.42

178

Other specified/unspecified soft tissue disorders

2.76

4.18

1.1

1.0

1.04

1.15

u/l

—

Other diseases of pleura

131

779

1.46

4.18

1.1

1.22

1.09

u/l

0.65

333

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

4.41

4.15

1.0

0.98

1.12

u/l

—

Other retinal disorders

205

1151

1.35

4.13

1.1

1.17

1.13

u/l

0.15

506

Continuous positive airway pressure

296

1.75

4.12

1.1

1.77

1.18

u/l

0.41

145

Injuries to the thorax

162

1160

1.40

4.11

1.1

1.11

1.13

u/l

0.04

485

Sequelae with surgical and medical care as external cause

442

1.66

4.10

1.1

1.24

1.14

u/l

0.24

188

Other cataract

138

709

1.45

4.09

1.2

1.1

1.20

1.12

u/l

0.27

340

Hyperplasia of prostate

102

369

1.56

4.07

1.1

1.11

1.20

u/l

0.35

178

Diseases of appendix

312

2200

1.27

4.01

1.1

1.05

1.13

u/l

0.81

119

906

Supplementary factors related to causes of morbidity and mortality classified elsewhere

127

877

1.45

3.98

1.1

1.06

1.08

u/l

0.16

347

Disorders of psychological development

356

1.70

3.97

1.1

1.35

1.02

u/l

0.90

139

Other coagulation defects

190

2.01

3.97

1.1

1.00

1.13

u/l

1.36

Psychotic depression

2.48

3.96

1.0

1.54

1.20

u/l

—

Disturbance of activity and attention

489

1.60

3.94

1.0

1.1

1.16

1.01

u/l

0.30

183

Appendicitis, broad definition

309

2190

1.27

3.94

1.1

1.06

1.13

u/l

0.78

118

904

Early onset COPD, excluding more controls

326

1.75

3.93

1.2

1.0

1.14

1.21

u/l

0.21

146

Other and unspecified mood [affective] disorders

212

1.94

3.91

1.1

1.0

0.96

1.05

u/l

1.13

Other noninfective gastroenteritis and colitis

637

1.53

3.88

1.1

1.21

1.12

u/l

0.40

254

Diseases of external ear

133

931

1.43

3.88

1.0

1.1

1.11

1.10

u/l

0.03

377

Infections of the skin and subcutaneous tissue

242

1832

1.30

3.86

1.1

1.05

1.12

u/l

0.60

103

749

Other problems related to primary support group, including family circumstances

349

1.71

3.83

1.1

0.95

1.06

u/l

1.37

139

Medial epicondylitis

2.70

3.83

1.1

1.14

1.10

u/l

—

Type of accident

117

804

1.46

3.78

1.1

1.06

1.08

u/l

0.07

317

Other acute lower respiratory infections

201

1440

1.33

3.76

1.1

1.11

1.13

u/l

0.07

589

Sicca syndrome [Sjögren]

174

2.02

3.73

1.1

1.18

1.17

u/l

0.02

Bacterial pneumoniae

139

865

1.41

3.73

1.1

1.21

1.08

u/l

0.82

361

Poisoning by medicine

106

717

1.48

3.72

1.1

1.09

1.07

u/l

0.10

284

Other disorders of binocular vision

4.21

3.72

1.1

0.95

1.18

u/l

—

Vitamin deficiency, wide

115

2.28

3.71

1.0

1.1

1.20

1.10

u/l

—

Vitamin deficiency

115

2.28

3.71

1.0

1.1

1.20

1.10

u/l

—

Cerebral aneurysm, nonruptured

168

2.03

3.69

1.0

1.1

1.63

1.19

u/l

—

Asthma and allergy

351

1.69

3.68

1.2

1.0

0.99

1.10

u/l

0.78

131

Other and unspecified disorders of vitreous body

130

895

1.42

3.68

1.1

1.02

1.14

u/l

3.39

410

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

242

1796

1.29

3.67

1.1

1.09

u/l

0.02

708

Otalgia

210

1.91

3.66

1.1

1.17

1.19

u/l

—

Autoimmune thyroiditis

2.90

3.64

1.4

1.0

0.90

1.12

u/l

—

Bacterial pneumonia (organism specified)

146

950

1.39

3.64

1.1

1.21

1.09

u/l

0.78

396

Retinal vascular occlusion

183

1.97

3.62

1.1

0.99

1.20

u/l

2.29

Retinal vascular disorders

183

1.97

3.62

1.1

0.99

1.20

u/l

2.29

Pulmonary embolism

593

1.52

3.59

1.1

1.04

1.13

u/l

0.87

253

Thyroiditis, ILD-related definition

262

1.80

3.59

1.1

1.02

1.14

u/l

0.79

121

Asthma and allergy, excluding more controls

354

1.68

3.58

1.2

1.0

0.99

1.11

u/l

0.84

130

Immunodeficiencies

117

2.24

3.58

1.3

1.1

1.02

1.08

u/l

—

Hodgkin lymphoma, hilmo

2.67

3.57

1.2

1.0

1.20

1.04

u/l

—

Pulmonary heart disease

594

1.52

3.56

1.1

1.04

1.13

u/l

0.89

253

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

124

758

1.43

3.56

1.0

1.1

1.21

1.03

u/l

0.67

278

Hypogonadotropic hypogonadism

2.59

3.56

1.2

1.1

1.10

1.06

u/l

—

Other arthrosis

184

917

1.35

3.56

1.1

1.07

1.15

u/l

0.77

385

Need for other prophylactic measures

137

2.13

3.55

1.2

1.1

1.27

1.17

u/l

0.36

Other bacterial intestinal infections, including avohilmo

579

1.52

3.54

1.1

1.21

1.10

u/l

0.32

240

Pulmonary heart disease, diseases of pulmonary circulation

627

1.50

3.54

1.1

1.05

1.12

u/l

0.75

263

Unspecified fall

187

1381

1.33

3.54

1.1

1.20

1.11

u/l

0.47

567

Cholecystitis

256

1.80

3.53

1.0

1.1

1.26

1.13

u/l

0.36

120

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

401

2077

1.22

3.53

1.1

1.18

1.10

u/l

0.34

170

844

Abnormal weight loss

199

1.92

3.52

1.2

1.1

1.16

u/l

0.00

Mixed connective tissue disease

3.66

3.51

1.2

1.1

1.20

1.13

u/l

—

Exposure to other specified factors

338

2350

1.24

3.49

1.1

1.09

1.12

u/l

0.27

136

952

Secondary uncertain malignant neoplasm

228

1.85

3.49

1.1

1.23

1.12

u/l

0.26

Vitreous haemorrhage

221

1.86

3.49

1.0

1.1

1.91

1.19

u/l

0.56

105

Acute lymphadenitis

172

1.99

3.49

1.1

0.95

1.07

u/l

1.52

Obsessive-compulsive disorder

214

1.88

3.48

1.1

1.00

1.03

u/l

0.21

Inflammatory diseases of prostate (prostatitis)

214

1.88

3.48

1.0

1.1

1.03

1.05

u/l

0.08

Neovascular glaucoma

2.63

3.47

1.2

1.1

1.07

1.16

u/l

—

Other/unspecified enthesopathies, not elsewhere classified

145

2.08

3.47

1.0

1.1

1.16

1.17

u/l

0.03

Superficial injury of lower leg

109

754

1.45

3.44

1.1

0.99

1.09

u/l

1.73

296

Benign neoplasm: Ascending colon

251

1.80

3.44

1.2

1.1

1.26

1.20

u/l

0.15

118

Anosmia

4.59

3.41

1.2

1.1

1.18

u/l

—

Acute appendicitis, no complications

240

1869

1.28

3.39

1.0

1.1

1.03

1.13

u/l

1.18

765

Problems related to lifestyle

282

1.74

3.38

1.1

0.95

1.05

u/l

1.44

119

Other predominantly sexually transmitted diseases, not elsewhere classified

636

1.48

3.34

1.0

1.1

1.03

1.08

u/l

0.36

229

Inflammatory disease of uterus

476

1.56

3.33

1.0

1.1

1.11

1.09

u/l

0.04

175

Obesity and other hyperalimentation

273

2045

1.26

3.33

1.1

1.22

1.10

u/l

0.37

108

821

Endometriosis ASRM stages 1,2

588

1.50

3.33

1.0

1.1

0.93

1.12

u/l

3.29

217

Calcific tendinitis of shoulder

108

2.23

3.32

1.0

1.1

1.04

1.11

u/l

0.46

Diseases of tongue

121

2.16

3.31

1.2

1.1

1.46

1.22

u/l

0.32

Other keratitis

314

1.69

3.31

1.0

1.1

1.34

1.10

u/l

0.50

130

Testicular hypofunction

2.43

3.31

1.0

1.1

0.87

1.10

u/l

—

Amblyopia ex anopsia

2.43

3.31

1.0

1.10

1.13

u/l

—

Hyperhidrosis

2.63

3.30

1.0

0.86

1.10

u/l

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

4.00

3.30

1.3

1.0

1.78

1.12

u/l

—

Glaucoma secondary to other eye disorders

2.55

3.30

1.2

1.0

1.07

1.24

u/l

—

Other hearing loss

493

1.53

3.27

1.1

1.18

1.12

u/l

0.25

216

Other disorders of adrenal gland

109

2.22

3.26

1.4

1.0

1.24

1.06

u/l

0.67

Fall on and from stairs and steps

101

697

1.45

3.25

1.0

1.1

1.09

1.11

u/l

0.05

286

Other viral diseases, not elsewhere classified

525

1.52

3.24

1.1

1.09

1.10

u/l

0.02

212

Dermatophytosis

301

1.70

3.23

1.1

1.08

1.12

u/l

0.19

138

Obesity

271

2040

1.25

3.22

1.1

1.22

1.10

u/l

0.37

108

819

Other disorders of patella

488

1.54

3.22

1.0

1.1

1.10

1.09

u/l

0.07

181

Allergic conjunctivitis

250

1907

1.26

3.21

1.1

1.08

1.10

u/l

0.11

760

Memory loss

143

2.04

3.20

1.5

1.1

0.97

1.19

u/l

1.86

Other and unspecified effects of external causes

121

866

1.40

3.20

1.1

1.10

u/l

0.02

349

Acute appendicitis

287

2145

1.24

3.20

1.1

1.06

1.13

u/l

0.69

114

889

Varicella [chickenpox], including avohilmo

123

2.12

3.19

1.0

1.41

1.18

u/l

0.34

Fracture of foot, except ankle

108

758

1.43

3.19

1.1

1.10

u/l

0.02

307

Renal tubulo-interstitial diseases

332

1984

1.23

3.18

1.1

1.17

1.11

u/l

0.47

124

820

Other congenital malformations of circulatory system

2.75

3.16

1.0

1.1

1.05

1.08

u/l

—

Heartburn

251

1.76

3.15

1.1

1.08

1.16

u/l

0.34

105

Diseases of pulp and periapical tissues and dental caries

228

908

1.29

3.15

1.1

1.09

1.14

u/l

0.50

100

396

Weight loss

222

1.81

3.14

1.2

1.1

1.15

1.18

u/l

0.08

110

Hyperkinetic disorders

518

1.51

3.13

1.0

1.1

1.16

1.00

u/l

0.33

192

All influenza (not pneumonia)

366

1.62

3.11

1.1

1.10

1.08

u/l

0.05

162

Endometriosis of rectovaginal septum and vagina

187

1.88

3.10

1.0

1.1

1.01

1.09

u/l

—

Sensorineural hearing loss

237

1243

1.27

3.09

1.1

1.11

1.14

u/l

0.22

105

541

Diseases of oral cavity, salivary glands and jaws

188

735

1.32

3.09

1.1

1.09

1.11

u/l

0.20

322

Monoamine oxidase A inhibitors

216

1.81

3.08

1.1

1.06

1.21

u/l

0.93

Necrosis of pulp, including avohilmo

252

1988

1.25

3.08

1.1

1.07

1.13

u/l

0.62

107

808

Conductive and sensorineural hearing loss

257

1357

1.26

3.07

1.1

1.12

1.14

u/l

0.14

113

593

Other superficial mycoses

2.71

3.07

1.5

1.1

1.04

1.05

u/l

—

Other and unspecified epidermal thickening

2.70

3.06

1.1

1.0

0.98

1.09

u/l

—

Statin medication

296

1344

1.24

3.05

1.1

1.14

1.10

u/l

0.27

118

540

Benign neoplasm: Skin of lower limb, including hip

2.60

3.05

1.1

0.95

1.07

u/l

—

Other diseases of stomach and duodenum

119

2.11

3.04

1.1

1.0

1.05

1.19

u/l

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

642

1.45

3.03

1.0

1.1

0.96

1.09

u/l

2.47

232

Secondary hypertension

144

1.99

3.02

1.0

1.1

1.00

1.08

u/l

—

Hyperlipidaemia, other/unspecified

106

672

1.42

3.01

1.1

1.14

u/l

0.02

300

Other noninflammatory disorders of vulva and perineum

270

1.71

3.00

1.1

1.04

1.10

u/l

0.42

102

Tonsillectomy and adenotomy

279

1565

1.24

3.00

1.1

1.04

1.09

u/l

0.43

116

593

Internal derangement of knee

141

1036

1.35

3.00

1.0

1.1

0.96

1.14

u/l

3.28

415

Disorders of parathyroid gland

366

1.60

2.97

1.1

1.31

1.16

u/l

0.39

163

Mouth breathing

139

1030

1.35

2.97

1.0

1.1

1.11

1.15

u/l

0.14

455

Fracture of rib(s), sternum and thoracic spine

670

1.44

2.95

1.1

1.16

1.10

u/l

0.18

293

Brain meningioma, including Hilmo

101

2.19

2.93

1.0

1.1

2.27

1.18

u/l

0.37

Other diseases of anus and rectum

677

1.43

2.92

1.1

1.06

1.11

u/l

0.45

290

Fitting and adjustment of other devices

590

1.43

2.90

1.1

1.03

1.10

u/l

0.79

245

Carcinoma in situ of skin of other and unspecified parts of face

108

2.14

2.90

1.0

1.1

1.29

1.24

u/l

—

Perforation of tympanic membrane

243

1.74

2.89

1.1

1.12

1.11

u/l

0.04

107

Diaphragmatic hernia

110

790

1.39

2.89

1.1

1.16

1.11

u/l

0.33

353

Dental caries, including avohilmo

252

1028

1.26

2.87

1.1

1.10

1.13

u/l

0.35

101

452

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

289

1.67

2.87

1.1

1.06

1.10

u/l

0.20

118

Emotional disorders starting during childhood or adolecense, excluding more controls

105

2.13

2.86

1.1

1.0

0.92

1.02

u/l

—

Familial hypercholesterolemia

207

1.79

2.85

1.1

1.37

1.13

u/l

0.37

Meniscus derangement

191

983

1.29

2.83

1.1

1.11

1.15

u/l

0.18

411

Patent foramen ovale

2.79

2.82

1.0

0.94

1.23

u/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

179

1370

1.29

2.82

1.1

1.01

1.10

u/l

1.38

534

Unspecified haematuria

120

712

1.37

2.81

1.1

1.18

1.10

u/l

0.61

305

Testicular dysfunction

2.24

2.80

1.0

1.1

0.87

1.08

u/l

—

Noninflammatory disorders of female genital tract

175

670

1.31

2.80

1.1

1.11

1.08

u/l

0.19

261

Adhesive capsulitis of shoulder

291

1.65

2.80

1.0

1.1

1.01

1.14

u/l

1.46

134

Benign neoplasm: Choroid

137

1.98

2.80

1.1

1.19

1.18

u/l

0.01

Noninfective enteritis and colitis

179

1388

1.29

2.80

1.1

1.15

1.10

u/l

0.29

549

Other pleural conditions

151

1.93

2.79

1.1

1.0

1.16

1.21

u/l

0.11

Haemorrhoids and perianal venous thrombosis

109

781

1.39

2.79

1.1

1.06

1.10

u/l

0.37

333

Diseases of middle ear and mastoid

255

1682

1.24

2.78

1.1

1.14

1.08

u/l

0.43

104

648

Vasomotor and allergic rhinitis

159

1188

1.31

2.78

1.1

1.03

1.12

u/l

1.05

450

Haemorrhage from respiratory passages

100

628

1.41

2.78

1.1

1.09

1.16

u/l

0.33

265

Obesity due to excess calories

208

1648

1.26

2.77

1.1

1.29

1.09

u/l

0.50

643

Separation of retinal layers (serosa)

2.18

2.77

1.0

1.1

1.00

1.11

u/l

—

Other disorders of conjunctiva

269

1.68

2.77

1.1

1.21

1.17

u/l

0.06

123

Brain meningioma

2.18

2.77

1.0

1.1

0.95

1.18

u/l

1.45

Trigger finger

277

1.66

2.76

1.1

1.10

1.17

u/l

0.43

117

Chondropathies

418

1.54

2.75

1.0

1.1

1.02

1.12

u/l

1.22

179

Malignant neoplasm of breast

762

0.69

2.75

1.0

1.1

1.14

1.13

u/l

0.04

298

Other inflammation of eyelid

332

1.60

2.73

1.2

1.0

1.05

1.16

u/l

0.76

143

Malignant neoplasm of breast, HER2-negative

761

0.69

2.73

1.0

1.1

1.14

1.13

u/l

0.04

299

Malignant neoplasm of breast, including Hilmo

786

0.70

2.72

1.0

1.1

1.14

1.13

u/l

0.05

306

Malignant neoplasm of breast, HER2-negative, including Hilmo

786

0.70

2.72

1.0

1.1

1.14

1.13

u/l

0.05

306

KRA_PSY_EATING, excluding more controls

238

1.71

2.72

1.0

1.1

1.07

1.08

u/l

0.03

Other CVD

317

1.61

2.70

1.2

1.1

1.28

1.16

u/l

0.32

150

Scleritis

3.50

2.70

1.0

1.1

1.09

1.12

u/l

—

Other and unspecified drugs and medicaments

211

1.76

2.70

1.1

1.13

1.14

u/l

0.05

Disease of hard tissues of teeth, NOS

181

732

1.30

2.68

1.1

1.05

1.11

u/l

0.85

320

Lesion of radial nerve

2.34

2.65

1.0

1.1

1.40

1.14

u/l

—

Congenital malformations, deformations and chromosomal abnormalities

257

1986

1.23

2.64

1.1

1.05

1.12

u/l

0.72

113

764

Hypercalcemia

2.22

2.64

1.0

1.1

0.94

1.22

u/l

—

Excessive vomiting in pregnancy

281

1.65

2.64

1.1

1.00

1.08

u/l

0.59

Oter anti-inflammatory and antirheumatic agents, non-steroids

188

1.61

2.62

1.1

1.14

1.21

u/l

0.20

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

112

822

1.37

2.62

1.0

1.1

1.14

1.13

u/l

0.02

344

Otitis externa

645

1.41

2.62

1.0

1.1

1.15

1.12

u/l

0.05

258

Cholecystectomy

249

1718

1.23

2.61

1.1

1.22

1.12

u/l

0.87

703

Other disorders of penis

169

1.84

2.61

1.1

1.01

1.04

u/l

0.25

Use of levodopa decarboxylase inhibitor

221

1.72

2.60

1.1

1.0

1.06

1.23

u/l

1.21

102

Ganglion

530

1.46

2.59

1.1

1.03

1.12

u/l

0.64

208

Suicide or other Intentional self-harm

105

765

1.38

2.58

1.1

1.15

1.07

u/l

0.67

306

Menorrhagia

138

577

1.34

2.57

1.1

1.11

1.10

u/l

0.03

228

Bacterial intestinal infections, IBD co-morbidities

393

1.53

2.57

1.2

1.1

1.28

1.15

u/l

0.27

170

Disorders of synovium and tendon in diseases classified elsewhere

3.08

2.57

1.0

0.90

1.13

u/l

—

Lung diseases due to external agents

222

1.72

2.56

1.1

1.53

1.15

u/l

0.54

105

Convergent concomitant strabismus

149

1.89

2.56

1.1

1.09

1.06

u/l

0.10

Hypotension

260

1.66

2.56

1.2

1.1

1.35

1.21

u/l

0.30

121

Autoimmune hyperthyroidism

121

1.99

2.55

1.3

1.0

1.20

1.06

u/l

—

Disorder of lipoprotein metabolism, unspecified

200

1.75

2.55

1.1

1.0

1.18

1.14

u/l

0.10

Calculus of kidney and ureter

682

1.40

2.55

1.1

1.24

1.10

u/l

0.48

286

Congenital malformations of the nervous system

2.44

2.55

1.0

1.25

1.10

u/l

—

Venous thromboembolism

162

1212

1.29

2.54

1.1

1.06

1.14

u/l

0.97

521

Malignant melanoma of skin, including Hilmo

253

1.66

2.54

1.0

1.1

1.21

1.10

u/l

0.27

107

Injuries to the abdomen, lower back, lumbar spine and pelvis

142

1070

1.31

2.53

1.1

1.07

1.08

u/l

0.08

430

Lateral epicondylitis

277

1.63

2.51

1.1

1.14

1.13

u/l

0.01

121

Use of rivastigmine

171

1.81

2.51

1.2

1.1

1.02

1.27

u/l

2.22

Type 2 diabetes, wide definition

271

1402

1.22

2.50

1.1

1.16

1.15

u/l

0.04

116

602

DVT of lower extremities and pulmonary embolism

121

903

1.34

2.48

1.1

1.05

1.10

u/l

0.59

389

Acute pharyngitis

481

1.47

2.48

1.1

0.97

1.04

u/l

0.75

199

Gingivitis and periodontal diseases

373

1625

1.19

2.48

1.1

1.09

1.13

u/l

0.38

138

672

Endometriosis diagnosis and infertility diagnosis occurring together

397

1.52

2.48

1.0

1.1

0.87

1.04

u/l

5.61

143

Secondary polycythaemia

2.69

2.45

1.0

1.1

0.92

1.11

u/l

—

Chronic lymphocytic leukaemia, helper endpoint

2.68

2.45

1.2

1.0

0.96

1.18

u/l

—

Chronic lymphocytic leukaemia

2.68

2.45

1.2

1.0

0.96

1.18

u/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

2.68

2.45

1.2

1.0

0.96

1.18

u/l

—

Tongue abnormality

123

1.96

2.45

1.2

1.1

1.46

1.17

u/l

0.42

Other/unspecified soft tissue disorders related to use, overuse and pressure

2.47

2.45

1.1

1.0

1.09

u/l

—

Radial styloid tenosynovitis [de Quervain]

123

1.96

2.45

1.0

1.1

1.02

1.14

u/l

0.95

Other bullous disorders

2.57

2.45

1.2

1.0

1.11

1.07

u/l

—

Short Achilles tendon (acquired)

2.57

2.45

1.1

0.98

1.05

u/l

—

Other bacterial intestinal infections

398

1.51

2.44

1.1

1.30

1.12

u/l

0.43

172

Other and unspecified iron deficiency

111

822

1.35

2.44

1.0

1.1

1.33

1.10

u/l

1.07

322

Retinal detachment with retinal break

241

1.66

2.43

1.1

1.06

1.15

u/l

0.47

118

Other specified and unspecified retinal disorders

2.30

2.41

1.3

1.1

1.01

1.22

u/l

—

Varicella [chickenpox]

110

2.01

2.41

1.0

1.52

1.09

u/l

—

Agoraphobia

2.13

2.39

1.1

1.0

0.90

1.09

u/l

—

Status post-ami

336

0.54

2.39

1.0

1.1

1.51

1.14

u/l

—

166

N06DA Anticholinesterases

375

1.46

2.39

1.1

1.03

1.16

u/l

1.91

173

Use of anticholinesterases

375

1.46

2.39

1.1

1.03

1.16

u/l

1.91

173

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

2.22

2.38

1.0

1.1

1.07

1.08

u/l

—

Other maternal disorders predominantly related to pregnancy

248

1270

1.22

2.37

1.1

1.02

1.12

u/l

2.16

476

Methotrexate

282

1.60

2.36

1.2

1.0

1.33

1.17

u/l

0.36

116

Behavioural disorders, excluding more controls

2.62

2.35

1.1

1.74

1.00

u/l

—

Elevated blood glucose level

198

1.72

2.35

1.1

0.92

1.16

u/l

3.42

Spasmodic torticollis

2.27

2.35

1.1

1.18

1.11

u/l

—

Malignant neoplasm of digestive organs

593

0.66

2.34

1.1

1.87

1.09

u/l

0.57

266

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

275

2085

1.20

2.33

1.1

1.05

1.12

u/l

0.79

122

804

Disorders of breast

201

1426

1.24

2.33

1.1

1.15

1.10

u/l

0.29

550

Other diseases of hard tissues of teeth

180

735

1.27

2.32

1.1

1.10

1.11

u/l

0.03

322

Burns and corrosions confined to eye and internal organs

2.33

2.32

1.0

1.1

1.11

1.07

u/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

230

1.66

2.29

1.0

1.1

1.02

1.08

u/l

0.34

Normal-pressure hydrocephalus

2.38

2.29

1.3

1.1

1.17

1.28

u/l

—

Ischemic heart diseases

276

1363

1.21

2.29

1.1

1.11

1.17

u/l

0.49

126

600

Gastric ulcer

300

1.57

2.29

1.0

1.1

0.99

1.15

u/l

1.61

133

Autoimmune hepatitis, wide definition

2.13

2.29

1.0

0.96

1.10

u/l

—

Use of donepezil

219

1.66

2.28

1.1

1.02

1.21

u/l

1.75

106

Hypocalcemia

2.57

2.27

1.4

1.0

0.96

1.10

u/l

—

Malignant neoplasm of digestive organs, including Hilmo

645

0.68

2.27

1.1

1.73

1.09

u/l

0.58

288

Purpura and other haemorrhagic conditions

309

1.56

2.26

1.1

1.16

1.12

u/l

0.13

142

Urolithiasis

715

1.36

2.26

1.1

1.24

1.10

u/l

0.45

305

Recurrent dislocation and subluxation of joint

193

1.72

2.26

1.0

1.1

1.05

1.07

u/l

0.11

Unspecified abortion

135

1.86

2.22

1.0

1.10

1.04

u/l

0.20

Dislocation, sprain and strain of joints and ligaments of knee

256

1924

1.20

2.22

1.1

1.06

1.12

u/l

0.72

103

765

Melanocytic naevi

124

951

1.31

2.21

1.1

1.04

1.11

u/l

0.46

379

Diseases of liver

114

864

1.32

2.21

1.1

1.10

u/l

0.01

363

Assault by bodily force

248

1.62

2.21

1.1

1.08

1.05

u/l

0.22

109

Noninfectious colitis NAS

359

1.51

2.21

1.1

1.13

u/l

0.02

159

Superficial injury of wrist and hand

667

1.37

2.21

1.1

1.01

1.10

u/l

0.77

275

Enterocolitis due to Clostridium difficile

202

1.69

2.20

1.1

1.47

1.20

u/l

0.39

Unspecific neurodegenerative disorder

441

1.38

2.20

1.1

1.04

1.14

u/l

1.37

201

Caries of dentine, including avohilmo

268

1136

1.21

2.19

1.1

1.07

1.14

u/l

1.11

105

494

Presbyopia

180

1.73

2.18

1.0

1.1

0.94

1.12

u/l

2.67

Anogenital herpesviral [herpes simplex] infection, including avohilmo

418

1.46

2.17

1.1

1.04

1.03

u/l

0.07

148

Other disorders of glucose regulation and pancreatic internal secretion

211

1.66

2.16

1.0

1.1

1.07

1.14

u/l

0.33

Degeneration of macula and posterior pole

111

646

1.33

2.16

1.1

1.15

1.11

u/l

0.13

294

Nutritional anaemias

156

1178

1.26

2.15

1.0

1.1

1.55

1.10

u/l

1.00

489

Chronic kidney disease

531

1.40

2.13

1.1

1.35

1.12

u/l

0.68

245

Schizophrenia

462

0.58

2.13

1.0

1.1

1.36

1.07

u/l

—

198

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

220

1.64

2.11

1.0

1.1

1.18

1.14

u/l

0.13

102

Fracture of lower leg, including ankle

192

1533

1.23

2.11

1.1

1.21

1.13

u/l

0.40

622

Overexertion and strenuous or repetitive movements

267

1.58

2.11

1.0

1.1

1.07

1.12

u/l

0.24

120

Exposure to other and unspecified man-made environmental factors

2.47

2.11

1.0

1.08

1.06

u/l

—

Superficial injury of abdomen, lower back and pelvis

437

1.45

2.11

1.0

1.1

1.04

1.11

u/l

0.43

182

Bullous disorders

109

1.93

2.10

1.1

1.11

1.18

u/l

—

Adverse effects, not elsewhere classified

622

1.37

2.10

1.1

1.13

1.12

u/l

0.05

242

Other inflammation of eyelid, including avohilmo

183

1483

1.24

2.10

1.1

1.03

1.09

u/l

0.88

585

Unspecified dementia

1.98

2.09

1.0

1.1

1.34

1.23

u/l

—

Sulfasalazine

708

1.34

2.09

1.1

1.0

1.39

1.11

u/l

0.84

278

Protozoal diseases, including avohilmo

2.27

2.08

1.4

1.1

1.30

1.14

u/l

—

Retinal breaks without detachment

332

1.51

2.08

1.1

0.98

1.14

u/l

3.21

153

Disorders of gallbladder, biliary tract and pancreas

361

1928

1.17

2.07

1.1

1.17

1.12

u/l

0.40

135

797

Other and unspecified injuries of lower leg

206

1.66

2.07

1.1

1.22

1.11

u/l

0.26

Other appendicitis

206

1.66

2.07

1.1

0.89

1.14

u/l

—

Iron deficiency anaemia

135

1037

1.28

2.07

1.1

1.57

1.09

u/l

0.96

417

Erysipelas, including avohilmo

238

1464

1.20

2.06

1.1

1.22

1.11

u/l

0.65

602

Complications of genitourinary prosthetic devices, implants and grafts

2.34

2.05

1.1

1.04

1.12

u/l

—

Degenerative macular diseases

176

1.71

2.05

1.1

1.07

1.18

u/l

0.64

Diabetes mellitus

409

2048

1.15

2.03

1.1

1.09

1.13

u/l

0.28

168

835

Pneumonitis due to solids and liquids

132

1.82

2.03

1.1

1.0

1.63

1.20

u/l

0.43

Pre-eclampsia or poor fetal growth

144

1136

1.26

2.02

1.0

1.1

1.02

1.09

u/l

0.83

429

Early lumbar disc prolapse operation

375

1.47

2.02

1.1

1.05

1.04

u/l

0.08

147

Other disorders of male genital organs

2.12

2.02

1.0

1.1

1.16

1.03

u/l

—

Other disorders of white blood cells

125

1.85

2.02

1.2

1.1

0.97

1.15

u/l

1.87

Bicipital tendinitis

2.06

2.01

1.0

1.01

1.23

u/l

—

Ovarian dysfunction

303

1.52

2.00

1.0

1.1

1.32

1.01

u/l

0.54

105

Other and unspecified anaemias

114

824

1.30

1.99

1.1

1.22

1.10

u/l

0.67

355

Nail disorders

224

1.61

1.99

1.1

1.00

1.08

u/l

0.69

103

Transplanted organ and tissue status

224

1.61

1.99

1.1

1.08

1.17

u/l

0.46

105

Vasomotor rhinitis (mode)

178

1.69

1.98

1.1

1.01

1.12

u/l

0.56

Superficial injury of neck

2.30

1.98

1.1

0.98

1.07

u/l

—

Hypertrophic disorders of skin

163

1.73

1.98

1.1

1.01

1.08

u/l

0.43

Dental operations

196

820

1.23

1.98

1.1

1.06

1.18

u/l

1.37

359

Spinal instabilities

2.30

1.98

1.0

1.1

1.02

1.05

u/l

—

Protozoal diseases

2.30

1.98

1.4

1.1

1.30

1.10

u/l

—

Open wound of wrist and hand

175

1373

1.23

1.98

1.0

1.1

1.00

1.14

u/l

2.63

572

Fracture at wrist and hand level

130

1018

1.27

1.97

1.0

1.1

1.21

1.13

u/l

0.21

421

Paralytic ileus and intestinal obstruction

510

1.39

1.97

1.1

1.03

1.13

u/l

0.75

227

Other specified and unspecified disorders of eye and adnexa

2.04

1.96

1.1

0.95

1.11

u/l

1.05

Chronic gastritis

511

1.39

1.96

1.1

1.18

1.12

u/l

0.16

219

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

197

1405

1.22

1.95

1.0

1.1

1.03

1.11

u/l

1.28

541

Excessive attrition of teeth

250

2084

1.19

1.95

1.1

1.23

1.10

u/l

0.80

849

Chronic conjunctivitis

2.20

1.94

1.2

1.1

0.99

1.08

u/l

—

Parkinson's disease, including avohilmo

249

1.57

1.94

1.1

1.02

1.22

u/l

2.01

112

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

555

1.37

1.93

1.1

1.07

1.05

u/l

0.17

211

Injury of muscle and tendon at wrist and hand level

338

1.48

1.93

1.2

1.1

1.34

1.11

u/l

0.62

155

Achilles tendinitis

195

1.65

1.92

1.0

1.1

0.94

1.15

u/l

2.15

Cardiodefibrillation

641

0.67

1.92

1.0

1.1

0.92

1.18

u/l

3.57

288

Diseases of arteries, arterioles and capillaries (FINNGEN)

339

1.41

1.92

1.1

1.16

1.21

u/l

0.13

167

Allergic urticaria

219

1.60

1.90

1.1

1.44

1.12

u/l

—

Rosacea

372

1.46

1.90

1.1

1.0

0.91

1.16

u/l

5.37

151

Anogenital herpesviral [herpes simplex] infection

227

1.59

1.90

1.2

1.1

1.04

1.05

u/l

0.04

Heart failure, not strict

227

1271

1.20

1.90

1.1

1.25

1.15

u/l

0.57

106

551

Schizophrenia or delusion, excluding more controls

745

1.31

1.90

1.1

1.04

1.11

u/l

0.53

304

Other anaemias

114

828

1.29

1.89

1.1

1.22

1.10

u/l

0.67

356

Candidiasis

389

1.44

1.89

1.1

1.32

1.14

u/l

0.45

157

Any event in cancer register

364

1840

1.16

1.89

1.1

1.30

1.08

u/l

1.29

158

732

Diabetes, varying definitions

405

2048

1.15

1.89

1.1

1.10

1.13

u/l

0.22

164

839

Cardiomyopathy, other and unspecified

143

1.75

1.88

1.2

1.1

1.04

1.17

u/l

0.84

Other disorders of bone density and structure

2.17

1.88

1.0

1.1

1.70

1.05

u/l

—

Other and unspecified iridocyclitis

121

1.83

1.88

1.2

1.1

1.13

1.10

u/l

—

Injuries to the shoulder and upper arm

305

2016

1.17

1.88

1.1

1.13

1.14

u/l

0.07

126

831

conjunctival haemorrhage

151

1.73

1.86

1.2

1.1

1.30

1.15

u/l

—

Seronegative rheumatoid arthritis

236

1.57

1.86

1.0

1.36

1.12

u/l

0.50

103

Other and unspecified tonsillitis

154

1031

1.24

1.86

1.1

1.04

1.11

u/l

0.42

408

Impingement syndrome of shoulder

457

1.40

1.86

1.0

1.1

1.05

1.21

u/l

0.75

210

L04AD Calcineurin inhibitors

276

1.53

1.86

1.0

1.1

1.11

1.12

u/l

0.07

127

Medicines for HER+ breast cancer

824

0.72

1.85

1.0

1.1

1.01

1.16

u/l

2.08

343

Pregnancy hypertension

184

1352

1.22

1.85

1.0

1.1

1.00

1.10

u/l

2.42

509

Osteonecrosis

129

1.79

1.85

1.0

1.1

1.15

1.17

u/l

—

Type 2 diabetes

385

1940

1.15

1.85

1.1

1.10

1.13

u/l

0.22

158

797

Tuberculosis, wide, including avohilmo

100

1.91

1.85

1.3

1.0

1.21

1.25

u/l

—

Reactive arthropathies, FINNGEN

159

1.70

1.85

1.0

0.90

1.09

u/l

—

Other epidermal thickening

1.94

1.85

1.1

0.96

1.13

u/l

—

Impotence

1.94

1.85

1.2

1.1

1.33

1.10

u/l

—

Cerebral atherosclerosis

3.55

1.83

1.0

—

1.08

—

Caries of enamel

384

2191

1.15

1.83

1.1

1.17

1.11

u/l

0.37

143

897

Single delivery by caesarean section

447

0.70

1.83

1.1

1.00

1.04

u/l

0.34

150

Coronary artery bypass grafting

320

0.60

1.83

1.0

1.1

1.49

1.15

u/l

0.66

161

Blepharochalasis

535

1.37

1.83

1.1

1.09

1.16

u/l

0.56

234

Viral warts, including avohilmo

664

1.33

1.83

1.0

1.1

1.14

1.11

u/l

0.08

264

Anankastic personality disorder

130

1.78

1.82

1.0

1.1

1.18

1.05

u/l

0.39

Atherosclerosis, excluding cerebral and coronary sclerosis

546

0.69

1.80

1.0

1.1

1.03

1.14

u/l

0.73

250

Ménière disease

191

1.63

1.80

1.0

1.01

1.16

u/l

1.30

100

Malignant neoplasm, wide definition

334

1679

1.16

1.80

1.1

1.34

1.07

u/l

1.54

151

662

Polycystic ovarian syndrome, consortium definition

300

1474

1.17

1.80

1.1

1.04

1.11

u/l

1.04

119

560

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

317

1.48

1.80

1.1

0.99

1.08

u/l

0.62

127

Tuberculosis, IBD comorbidity

1.92

1.80

1.3

1.1

1.21

1.25

u/l

—

Unspecified event, undetermined intent

2.18

1.78

1.1

1.00

1.05

u/l

—

Infections of genitourinary tract in pregnancy

320

1.47

1.78

1.1

0.94

1.13

u/l

2.84

109

Hypoglycaemia, other or unspecified

169

1.66

1.77

1.0

1.1

1.09

u/l

0.00

Diseases of peritoneum

200

1.60

1.76

1.1

1.02

1.13

u/l

1.00

104

Recurrent dislocation of patella

177

1.65

1.76

1.1

1.0

1.62

1.03

u/l

0.53

Primary angle-closure glaucoma

2.10

1.76

1.1

1.0

0.93

1.26

u/l

—

Hyperparathyroidism

309

1.47

1.75

1.0

1.36

1.15

u/l

0.44

142

Unspecified lump in breast

404

1.41

1.75

1.2

1.1

1.28

1.10

u/l

0.34

160

Special screening examination for neoplasms

1.94

1.74

1.1

1.0

1.06

1.14

u/l

—

Helminthiases, including avohilmo

117

1.80

1.74

1.0

1.20

1.07

u/l

—

Other abnormal findings of blood chemistry

117

1.80

1.74

1.1

0.97

1.14

u/l

—

Reactive arthropathies

201

1.60

1.74

1.1

0.95

1.11

u/l

2.10

1.89

1.73

1.1

1.03

1.17

u/l

—

Ankylosing spondylitis, ICD10

233

1.55

1.73

1.1

1.46

1.07

u/l

0.58

107

Burn and corrosion confined to eye and adnexa

2.15

1.72

1.0

1.1

1.16

1.07

u/l

—

Tubulo-interstitial nephritis, not specified as acute or chronic

140

1.72

1.71

1.1

1.49

1.14

u/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

663

1.31

1.71

1.0

1.1

1.18

1.09

u/l

0.39

277

Hypoparathyroidism

2.07

1.70

1.3

1.0

1.20

1.24

u/l

—

Other condition

373

1.42

1.70

1.1

1.10

1.09

u/l

0.04

158

Postprocedural disorders of digestive system, not elsewhere classified

2.07

1.70

1.0

1.23

1.17

u/l

—

Later onset COPD

309

0.60

1.70

1.0

1.1

1.22

1.15

u/l

—

146

Urethral stricture

1.96

1.69

1.0

1.09

1.18

u/l

—

Adenomyosis (Endometriosis of uterus)

348

1.44

1.69

1.1

1.25

1.08

u/l

0.35

140

Leisure time condition

475

1.37

1.68

1.1

1.04

1.13

u/l

0.60

193

Pre-eclampsia or eclampsia

726

1.30

1.68

1.0

1.1

0.99

1.14

u/l

2.61

268

Other and unspecified nail disorders

2.20

1.68

1.2

1.1

0.92

1.11

u/l

—

Mixed and other personality disorders

243

1.53

1.67

1.1

1.04

1.05

u/l

0.05

105

Deep endometriosis

284

1.48

1.66

1.0

1.1

0.97

1.15

u/l

1.56

114

Volume depletion

149

1.68

1.66

1.1

1.0

1.09

1.11

u/l

—

Car occupant injured in other and unspecified transport accidents

597

1.33

1.65

1.1

1.04

1.06

u/l

0.11

236

Atopic dermatitis

255

1738

1.17

1.65

1.1

1.09

1.11

u/l

0.11

683

Fall on same level involving ice and snow

203

1708

1.19

1.65

1.1

1.26

1.12

u/l

0.88

691

Other sexually transmitted chlamydial diseases

252

1.51

1.65

1.0

1.1

1.00

1.01

u/l

—

Other embolism and thrombosis

260

1.50

1.65

1.0

1.1

0.98

1.17

u/l

2.37

119

Major coronary heart disease event

259

1324

1.17

1.64

1.1

1.06

1.17

u/l

1.65

120

589

Undefined dementia

103

1.79

1.63

1.0

1.34

1.24

u/l

—

Lesion of sciatic nerve

2.25

1.63

1.0

1.30

1.29

u/l

—

Other diseases of oesophagus

173

1.62

1.63

1.1

1.02

1.19

u/l

1.52

Unspecified privation

261

1.50

1.62

1.1

1.16

1.11

u/l

0.15

124

Malignant melanoma, including Hilmo

302

1.46

1.62

1.1

1.20

1.10

u/l

0.26

126

Adjustment and management of implanted device

253

1.50

1.62

1.1

1.09

1.15

u/l

0.26

109

Atrial fibrillation and flutter

439

1.31

1.62

1.1

1.00

1.19

u/l

1.20

197

Behavioural disorders

2.16

1.61

1.1

1.0

1.74

1.04

u/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

591

0.73

1.61

1.0

1.1

1.00

1.13

u/l

1.46

248

Abnormal findings in secretions and smears from cervix uteri vagina vulva

220

1372

1.18

1.60

1.0

1.1

1.07

1.10

u/l

0.13

521

Torsion of ovary, ovarian pedicle and fallopian tube

2.08

1.60

1.1

1.00

1.07

u/l

—

Use of antiglaucoma preparations and miotics

113

1.77

1.60

1.3

1.0

1.06

1.24

u/l

—

Agranulocytosis

246

1.51

1.59

1.1

1.21

1.15

u/l

0.28

115

L02BA Anti-estrogens

376

0.61

1.59

1.1

1.00

1.16

u/l

1.19

164

Cholelithiasis, broad definition with cholecystitis

305

1764

1.15

1.59

1.1

1.17

1.12

u/l

0.43

118

724

Missing teeth due to accident, extraction or parodontitis

189

1416

1.19

1.59

1.1

1.14

1.13

u/l

0.03

614

Malignant neoplasm of breast, HER-positive

590

0.73

1.58

1.0

1.1

1.00

1.13

u/l

1.47

247

Malignant neoplasm, including Hilmo

330

1678

1.15

1.58

1.1

1.34

1.07

u/l

1.57

149

663

Tuberculosis, wide

1.82

1.57

1.3

1.1

1.21

1.25

u/l

—

Other disorders of the genitourinary system

247

1.50

1.57

1.0

1.1

1.04

1.16

u/l

0.95

112

Other/unspecified synovitis and tenosynovitis

223

1.53

1.56

1.1

1.08

1.15

u/l

0.37

Pre-eclampsia

682

1.29

1.56

1.0

1.1

0.99

1.15

u/l

2.77

249

Conduct disorder

2.12

1.55

1.1

1.0

1.74

1.03

u/l

—

Other sexually transmitted chlamydial diseases, including avohilmo

389

1.39

1.55

1.0

1.1

0.96

1.00

u/l

0.36

142

Gluteal tendinitis

1.93

1.54

1.1

1.52

1.12

u/l

—

Specific development disorders of scholastic skills

127

1.70

1.54

1.0

1.1

0.93

0.98

u/l

—

Mitochondrial myopathy

3.41

1.53

1.0

1.1

—

1.11

—

Rheumatoid arthritis, including avohilmo

116

932

1.25

1.53

1.1

1.30

1.12

u/l

0.80

385

Nonspecific lymphadenitis

153

1.64

1.53

1.2

1.1

1.03

1.05

u/l

0.21

Other and unspecified papulosquamous disorders

3.38

1.53

1.2

1.0

—

1.17

—

Perineal laceration during delivery

616

0.73

1.53

1.0

1.1

1.17

1.02

u/l

0.75

208

Endometriosis of ovary

455

1.35

1.53

1.0

1.1

0.90

1.08

u/l

5.39

178

Occlusion and stenosis of arteries, not leading to stroke

3.35

1.52

1.0

1.1

—

1.03

—

Bacterial, viral and other infectious agents, including avohilmo

257

1.48

1.52

1.0

1.1

0.89

1.08

u/l

—

117

Diseases of the digestive system

132

1069

1.23

1.51

1.1

1.10

1.09

u/l

0.07

444

Sudden idiopathic hearing loss

217

1.52

1.51

1.1

1.08

1.17

u/l

0.29

109

Injury of nerves at wrist and hand level

108

1.77

1.51

1.1

1.09

u/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.87

1.50

1.3

1.1

1.11

1.05

u/l

—

Tobacco use

154

1.63

1.50

1.1

0.96

1.11

u/l

1.29

Other diseases of liver

460

1.35

1.49

1.0

1.1

1.16

1.12

u/l

0.14

200

Ankylosing spondylitis, strict definition

131

1.69

1.49

1.0

1.1

1.70

1.08

u/l

—

Dermatitis due to substances taken internally

131

1.69

1.49

1.2

1.0

1.01

1.06

u/l

—

Benign neoplasm: Descending colon

131

1.68

1.49

1.2

1.1

1.27

1.21

u/l

0.09

Thrombocytopenia, unspecified

162

1.61

1.49

1.1

1.24

1.18

u/l

0.19

Seborrhoeic dermatitis

218

1.52

1.48

1.1

1.01

1.13

u/l

0.89

101

Benign neoplasm of major salivary glands

202

1.54

1.48

1.1

1.18

1.20

u/l

0.02

102

Diabetes medication

401

2082

1.12

1.47

1.1

1.10

1.13

u/l

0.26

164

852

Alzheimer’s disease, strict definition

241

1.44

1.47

1.1

1.02

1.21

u/l

2.23

120

Other disorders of breast

402

1.37

1.46

1.1

1.0

0.94

1.07

u/l

2.67

150

Percutaneous Coronary Intervention

241

1260

1.16

1.46

1.1

1.07

1.16

u/l

1.36

111

569

Peripheral artery disease

607

0.74

1.46

1.1

1.02

1.12

u/l

0.64

278

Other disorders of pigmentation

1.85

1.46

1.1

1.09

1.20

u/l

—

Excessive, frequent and irregular menstruation

152

669

1.21

1.45

1.0

1.1

1.05

1.08

u/l

0.30

261

Intestinal stricture

645

1.29

1.45

1.1

1.10

1.12

u/l

0.06

274

Arthrosis

245

1155

1.16

1.45

1.1

1.18

1.14

u/l

0.20

108

470

Other superficial mycoses, including avohilmo

352

1.40

1.45

1.2

1.1

0.94

1.07

u/l

2.16

139

Other neurotic disorders

1.88

1.44

1.1

1.22

1.14

u/l

—

Amenorrhoea

236

1.49

1.44

1.2

1.1

1.08

1.04

u/l

0.19

Chondromalacia

1.98

1.43

1.0

0.95

1.13

u/l

—

Other disorders of cornea

228

1.50

1.43

1.0

1.1

1.05

1.12

u/l

0.32

108

Misadventures to patients during surgical and medical care

336

1.40

1.43

1.1

1.08

1.16

u/l

0.40

141

Aplastic and other anaemias

120

893

1.23

1.42

1.1

1.22

1.11

u/l

0.71

381

Obesity, other/unspecified

138

1141

1.21

1.42

1.1

1.14

1.11

u/l

0.10

438

Presence of other devices

440

1.34

1.41

1.1

1.14

1.15

u/l

0.04

187

Insulin, combination of fast acting with intermediate-acting or long-acting

194

1498

1.17

1.41

1.1

1.25

1.13

u/l

0.64

633

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

233

1.48

1.41

1.0

1.1

0.90

1.08

u/l

—

Erosion of teeth , including avohilmo

113

916

1.24

1.41

1.1

1.11

1.08

u/l

0.11

358

Budesonide

354

1.39

1.41

1.1

1.0

1.04

1.11

u/l

0.46

139

Disorders of tooth development and eruption

370

1.34

1.40

1.1

1.10

1.12

u/l

0.07

157

Other eating disorders

181

1.55

1.39

1.0

0.94

1.05

u/l

—

Fentanyl

149

1.61

1.39

1.0

1.1

1.15

1.24

u/l

—

Superficial injury of head

596

1.29

1.39

1.1

1.03

1.11

u/l

0.85

236

Erythema nodosum

1.90

1.39

1.0

1.1

1.17

1.11

u/l

—

Emergency coronary revascularization (for ACS)

252

1319

1.15

1.38

1.1

1.08

1.16

u/l

1.10

116

594

Other and unspecified vascular occlusions

142

1.62

1.38

1.2

1.1

1.00

1.22

u/l

—

Other bursopathies

222

1.49

1.38

1.0

1.1

1.31

1.15

u/l

0.18

Parkinson's disease, strict definition

222

1.49

1.38

1.2

1.1

1.00

1.23

u/l

2.29

103

Suppurative and unspecified otitis media

159

1182

1.19

1.37

1.1

1.23

1.07

u/l

0.70

445

Other infectious diseases

150

1.60

1.37

1.1

1.0

1.04

1.17

u/l

—

Congenital malformations of the circulatory system

362

1.37

1.0

1.1

1.00

1.11

u/l

0.91

162

Sulfonylureas

420

0.70

1.37

1.0

1.1

1.09

1.13

u/l

0.12

201

Emotional disorders and disorders of social functioning with onset specific to childhood

147

1.60

1.37

1.1

1.0

0.92

0.98

u/l

—

Alzheimer disease

295

1.36

1.1

1.04

1.19

u/l

1.57

140

Coronary revascularization (ANGIO or CABG)

240

1261

1.16

1.36

1.1

1.07

1.16

u/l

1.36

111

569

Female genital prolapse

100

442

1.26

1.36

1.0

1.1

1.13

1.12

u/l

0.04

176

Cyst of kidney

135

1.63

1.35

1.1

1.23

1.21

u/l

—

Assault

434

1.34

1.35

1.1

1.07

1.04

u/l

0.37

179

Cellulitis

591

1.29

1.35

1.1

1.13

1.09

u/l

0.08

245

Benign neoplasm: Transverse colon

207

1.50

1.35

1.1

0.97

1.15

u/l

2.37

100

Other specified and unspecified personality disorders

273

1.43

1.35

1.1

1.38

1.07

u/l

0.49

114

Other infestations, including avohilmo

0.00

1.34

0.0

1.0

—

1.13

—

Thyroiditis

175

1.55

1.34

1.2

1.1

0.94

1.10

u/l

1.52

All chronic kidney diseases

165

1110

1.19

1.33

1.1

1.23

1.12

u/l

0.50

470

Iron deficiency

105

1.72

1.33

1.2

1.0

0.95

1.10

u/l

—

Multiple myeloma, including Hilmo

1.92

1.33

1.2

1.1

1.04

1.14

u/l

—

Foreign body in alimentary tract

128

1.65

1.33

1.0

1.1

1.65

1.12

u/l

—

Other female pelvic inflammatory diseases

444

1.33

1.0

1.1

1.02

1.14

u/l

0.94

178

Keratoconus

1.98

1.33

1.0

1.1

1.14

1.09

u/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

114

932

1.22

1.33

1.1

1.14

1.12

u/l

0.12

383

Sacrococcygeal disorders, not elsewhere classified

1.98

1.33

1.1

1.09

1.05

u/l

—

Otitis externa, unspecified

316

1.40

1.32

1.0

1.1

1.29

1.13

u/l

0.23

131

Prolonged pregnancy

585

0.74

1.32

1.0

1.1

0.90

1.06

u/l

—

205

Congenital malformations and deformations of the musculoskeletal system

256

1.44

1.32

1.1

0.99

1.09

u/l

0.61

101

Other infectious diseases, including avohilmo

200

1.50

1.32

1.2

1.1

1.12

1.16

u/l

0.12

Parkinson's disease

241

1.45

1.31

1.1

1.02

1.21

u/l

1.81

108

Dermatophytosis, including avohilmo

239

2041

1.15

1.31

1.1

1.02

1.13

u/l

2.29

113

812

Myocardial infarction, strict

686

0.78

1.31

1.1

1.29

1.15

u/l

0.64

330

Rheumatoid arthritis

658

1.25

1.31

1.1

1.37

1.09

u/l

1.14

270

Macular pucker

258

1.44

1.31

1.2

1.1

1.04

1.17

u/l

1.46

120

Other and unspecified urticaria

586

1.28

1.30

1.1

1.10

1.11

u/l

0.04

226

Myocardial infarction

738

0.79

1.29

1.1

1.25

1.15

u/l

0.49

350

Injuries to the hip and thigh

139

1041

1.20

1.29

1.1

1.16

1.09

u/l

0.31

438

Other disorders starting during childhood or adolecense, excluding more controls

101

1.70

1.29

1.1

1.02

0.99

u/l

—

Malignant neoplasm of endocrine gland, including Hilmo

185

1.52

1.29

1.0

1.1

1.24

1.11

u/l

0.34

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS